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Abstract
Shareholder investments declined in Jordanian pharmaceutical business expansion
between 2007 and 2014, which included a reduction in the supply of essential medicines
in the Middle East and North Africa (MENA). The purpose of this qualitative multiple
case study was to explore effective applications of expansion strategies to satisfy demand
in the MENA markets among Jordanian generic pharmaceutical companies’ managers.
The conceptual framework for this study was based on the transformational leadership
theoryandstakeholders’theory. The purposive sample consisted of 4 chief executive
officers and 8 managers from Jordanian pharmaceutical companies who practiced the
expansion strategy in the MENA for more than 10 years. The data were triangulated from
semistructured interviews and cash flow financial statements. Interpretation summaries of
theparticipants’answers were applied for the member-checking process to bolster the
trustworthiness of interpretations. Four themes emerged from the analysis process:
leaders’ adaptabilitytochange,financialcapacityandstability,stakeholders’business
awareness,andmanagers’engagementsandknowledge. The findings may provide the
generic pharmaceutical business leaders and managers with increased growth capabilities
for catalyzing beneficial positive capacity expansion strategies. The subsequent
expansion could provide adequate, affordable, and accessible medications for effecting
social changes by fighting disease in remote and low-income MENA communities.
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Section 1: Foundation of the Study
Demand for pharmaceuticals is increasing in populated regions of the world,
especially in low-income parts of the Middle East and North Africa (MENA) (World
Health Organization, 2014). Generic pharmaceutical industries in the middle-income
regions of the MENA region provided solutions for the pharmaceutical availability, in
which effective strategies implementation for the pharmaceutical business expansion
contributed to profits generation in the targeted MENA regions (Cameron, MantelTeeuwisse, Leufkens, & Laing, 2012). Generic pharmaceutical industry leaders in Jordan
are developing business systems according to international standard requirements and
they are expanding in developed and developing regions of the world (Sharabati, Naji
Jawad, & Bontis, 2010; Sharabati, 2013). Expansions strategies among successful leaders
rely on the capabilities to gain value and respond to customers in competitive business
models that will satisfy demands of low-income people in MENA and attain profitability
for pharmaceutical industry shareholders (Dylst, Vulto, Godman, & Simoens, 2013).
Background of the Problem
Professionals and practitioners have focused attention on the competitive
advantages of pharmaceutical markets with regard to leveraging profitability and
discovering business opportunities (Ahmad, Khoso, Zubair, & Ahmed, 2014; Dixit &
Yadav, 2015; Srivastava & Prakash, 2014). Professionals and practitioners from
developed countries applied expansion strategies based on gained and practiced
marketing knowledge, organization systems, and production expertise to form
competitive advantages for expanding the pharmaceutical business in different regions in
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the world, including MENA (Esper, Ellinger, Stank, Flint, & Moon, 2010). Generic
pharmaceutical industry leaders developed industrial systems that matured through
adopting developed processes from product originators to comply with marketing
requirements in the developed regions of the globe (Pollock, 2014). Emerging economies
are opportunities for generic pharmaceutical industries to explore because of (a)
increasing demands for pharmaceuticals, (b) emerging chronic diseases, (c)
transformation to western fast food consumer style of leaving, and (d) international
regulation enforcement (African Development Bank and UN Development Program,
2014). Commercialization of generic pharmaceutical products, know-how expertise, and
systems in emerging economies are expanding business models that leaders are using to
satisfy the demands and generate business opportunities for the developing industrial
systems (Daems, Maes, Mehra, Carroll, & Thomas, 2014; Mastorakis & Siskos, 2016;
Vecchiato, 2012).
Researchers have addressed the scientific background requirements for managers
and their technical talents, educational levels, technical pharmaceutical skills, and
experiences requirements to implement pharmaceutical expansion business strategies
(Candi, Ende, & Gemser, 2013; Landry, Amara, Cloutier, & Halilem, 2013). Authors in
the current literature suggested further studies and research to fill the gap in knowledge
regarding the managerial and administrative competencies and perceptions of
pharmaceutical managers to implement expansion strategies in the pharmaceutical
business (Martín-Rojas, García-Morales, & Bolívar-Ramos, 2013; Teirlinck & Spithoven,
2013). Authors of pharmaceutical expansion business models have discussed
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intertechnology transfer, licensing, and franchising and have focused on aspects related to
internal developed business model applicability to legalization, human resources,
cultures, and infrastructures requirements (Casado & Peláez, 2014; Mehralian, Rasekh,
Akhavan, & Ghatari, 2013; Sharabati et al., 2010). In addition, the regulatory codes for
themanagementqualificationfor“safe,pure,andeffective”pharmaceuticalproduct
manufacturing enforced the scientific, technical, and engineering skills (Food and Drug
Administration [FDA], 2001). Exploring the combination effectiveness of FDA
requirement and managers perceptions in pharmaceutical business strategy
implementation is critical for advancing business knowledge. In this study, I explored
implementation of successful business expansion strategies related to manager
perceptions in the Jordanian pharmaceutical industry.
Problem Statement
Shareholder investments in Jordanian generic pharmaceutical business expansion
strategies declined during the last decade (Qader, Nour, & Hussein, 2013; Rafols et al.,
2014), which affected availability of medicine in the MENA region (UN
Millennium Development Goals, 2014). In 2013, generic pharmaceutical business leaders
failed to develop a business expansion strategy to satisfy demands for $26.2 billion of
supplies of essential medicines for developing countries in the MENA region (UN
Millennium Development Goals, 2014). The general business problem was that some
leaders in generic pharmaceutical organizations in Jordan lack management strategies for
developing business expansion to meet demands for generic pharmaceuticals for the
MENA markets. The specific business problem was that some Jordanian

4
pharmaceutical managers lack effective applications of expansion strategy to satisfy
demand in the MENA markets.
Purpose Statement
The purpose of this qualitative descriptive multiple case study was to explore
effective application of expansion strategy among Jordanian pharmaceutical managers to
satisfy the demand in the MENA markets. I interviewed four chief executive officers
(CEOs) and eight managers from generic pharmaceutical companies in Jordan who
practiced and succeeded in applying expansion strategies in the MENA region. I selected
participants purposely from Jordanian pharmaceutical managers who were experienced in
the professional application of expansion strategies in the MENA markets. My findings
may improve knowledge and efficacy of strategies and practices for expanding business
in the MENA region to satisfy potential market demands. The remote MENA
communities lack adequate pharmaceutical supplies and suffer from different diseases
that the generic essential medicines supplies could help resolve in communities (UN
Millennium Development Goals, 2014). These communities are potential stakeholders
who could benefit by increasing generic medical supplies, thereby meeting both
physician and patient needs for increasing availability and decreasing costs of generic
pharmaceuticals to fight diseases.
Nature of the Study
I proposed the qualitative research method for addressing the purpose of this
study. Yin (2014) posited that the application of qualitative studies is appropriate for the
collection of in-depthcontextfromparticipants’perceptionswithintheirnatural
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environment by direct contacts and observations. Quantitative and mixed-methods
formats were not appropriate for my study because the collection of quantifiable data of
different variables within hypothetical guided approaches is not applicable for exploring
perceptions of individuals (Zivkovic, 2012). Therefore, I used the qualitative method and
explored effective expansion strategies that Jordanian pharmaceutical managers applied
to satisfy demands in the MENA markets.
Qualitative research designs include ethnography, narrative, and
phenomenological formats for focusing on culture, ethnic, and lived experiences of
participants (Denzin & Lincoln, 2011). The application of phenomenological design
includes similarities between participants within the affected phenomenon (Yadav, 2013).
I explored, analyzed, interpreted, and addressed differentcompanies’strategies,visions,
and practices toaddressmystudy’spurpose. I did not use a phenomenological study
design because of the variation involving strategy implementation among companies,
CEOs, and managers.
Industrial entities comprise multicultural employees, and the purpose of this study
was to explore successful strategies for business expansion including different
communities in the MENA region and not cultural implications, which eliminates using
an ethnographic study. Individual experiences of storytelling were not appropriate for
conducting this study because of thestudy’s multiple exploration nature among many
CEOs and managers, which excludes the narrative study. Case study researchers can
employ open-ended interview questions to explore subjects experiences and to identify
theideasofparticipants(Yin,2014).Theresearcher’sroleistotranslatethemeaningsof
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the participants’responses and to code and theme meanings (Collins & Cooper, 2014).
Similarly, the case study approach allows further understandings through additional
exploratory questions to identify and characterize the core concept that the participants
experienced (Yin, 2014). The qualitative multiple case study design was, therefore, an
appropriate design for my study.
Research Question
The central research question was: What strategies do Jordanian pharmaceutical
managers apply for effective business expansion to satisfy the demand in MENA
markets?
Interview Questions
The interview questions I used were as follows:
1. What strategies do you use for expanding generic pharmaceutical capacity
for the MENA customers?
2. What challenges did or do you face in implementing the business expansion
strategies for this organization?
3. What are core business processes that improve expansion strategy in this
organization?
4. What are the principal barriers you faced or are facing in implementing the
expansion strategy?
5. How do you communicate and address the barriers with subordinates
working in expansion strategy?
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6. How did or do you address the principal barriers solutions or overcome in
your expansion strategy?
7. How do you evaluate expansion strategies implementations?
8. Whataremanagers’contributionstoexpansionstrategies?
9. How are managers’capabilitiessupporting expansion strategies in MENA
region?
10. What are supports you needed or need from shareholders to address the
expansion strategy?
11. How do you align the expansion strategy with the production capacity
design?
12. What other information, not addressed in the interview questions, are
pertinent to your development and implementation of expansion strategies
for generic pharmaceuticals in MENA region?
Conceptual Framework
I applied the transformational leadership theory as a conceptual framework for
this study. In addition to transformational leadership theory, stakeholder theory was an
appropriate element of my conceptual framework because of the affected groups
inclusion in the business expansion strategy. The following sections include my
conceptual framework for addressing the expansion strategy mechanisms for this study.
Transformational Leadership Theory
In 1978, Burns introduced a definition of transformational leadership to address
the process for leveraging mutual benefits for leaders and followers through morality and
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motivations (Northouse, 2013). Values are tools for transformational leaders that address
motives for identifying and achieving mutual objectives (Antonakis & House, 2014).
Leaders must equip followers with knowledge and skills to understand and achieve the
strategies objectives. In this study, I identified the expansion strategies for production
capacities stemming fromtransformationalleadership’seffectiveness in pharmaceutical
industries in Jordan. I explored thevaluesofleaders’contributionstoenhancing
commercialization processes through the lens of the transformational leadership.
Stakeholders’ Theory
Freeman’s (2010) definition of stakeholders depended on organizations’
interactions in business environments, which include parties from internal and external
surroundings of the organization. Freeman extended the affected parties to include
governments, competitors, suppliers, employees, and regulatory parties. The organization
activities involve changes, benefits, and developments, in which social interactions
consequences affect the organization’s strategic performance (Miles, 2012). Freeman
focused on identifying the benefiting and affected parties or individuals. In this study, I
applied stakeholders’theoryto the Jordanian pharmaceutical companies’ expanding
strategies in the MENA region, which Kazadi, Lievens, and Mahr (2015) posited as an
effective focus strategy for pharmaceutical companies’potential stakeholders. Valverde
(2013) suggested increasing stakeholder’sbenefitsby using corporate transparency,
complyingwithregulations,andraisingstakeholders’awarenessoftheinternal capacities
development requirements including external capacities for market access that involved
expansion strategies. In addition, the primary stakeholders in the expansion strategies are
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the investment sectors and the shareholders, for which return on investment and
increasing revenues are important expansion strategies objectives among pharmaceutical
organizations (Tripathy & Prajapati, 2014).
Operational Definitions
I used the following terms and definitions in this study:
Competitive advantage:Competitiveadvantageisthereasonsforcustomers’
preferences over other competitors and results in increasing sales, benefits, and retention
of customers (Bartlett & Ghoshal, 2013; Teixeira & Werther, 2013).
Expansion strategy: Expansion strategy is the application of procedures and
operations to achievecalculatedgrowththatdiffersfromthepreviousorganization’s
performance (Scott & Bruce, 1987).
Generic pharmaceutical: This term refers to a copied pharmaceutical product
from an originator after expired patent protection, which follows and possesses the
regulatory requirements at a lower price than the originator (Danzon, Mulcahy, & Towse,
2015).
Good manufacturing practice (GMP): Good manufacturing practice (GMP) is a
set of rules and regulations for pharmaceutical industries to follow during pharmaceutical
product formulation, processing, production, and packing according to the U.S. Federal
Food, Drug, and Cosmetic Act (Food and Drug Administration [FDA], 2001).
Managerial competency: This term refers to a group of skills, experiences, and
talents that managers possessed to achieve targets effectively and efficiently (Bhardwaj &
Punia, 2013).
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Organization’s performance: This refers to a multidimensional set of values,
targets, economic factors, social implications, and business objectives that researchers
applytodeterminetheeffectivenessoftheintentionsoforganizations’activities
(Camisón & Villar-López, 2014; Dess & Robinson, 1984).
Return on investment (ROI): Return on investment (ROI) is the outcome of
benefits or cost from the implementation of the specific process, strategy, product, or
service that stockholders, leaderships, managers, or employees view as primary factor for
evaluatingorganization’sperformance(McNulty,DeCieri,&Hutchings,2013).
Talent management: This term refers to a set of procedures, factors, and methods
that the human resource manager uses to attracting, recruiting, and retaining talented
employees to achieve the objectives (Festing & Schäfer, 2014).
Assumptions, Limitations, and Delimitations
Assumptions
Assumptions are the researcher’s anticipated issues in the research that the
researchers cannot control (Podsakoff, MacKenzie, & Podsakoff, 2012). I assumed that
participants in this study reflected reality and were honest in responding to the interview
questions. Participants agreed to participate in this study voluntarily until the data
collection method reached the saturation point. My selected analysis method of the data
and sample size were adequate to define themes. I assumed that my literature review
supported the participants’ responses for the research demography. I assumed that my
findings might add to professional knowledge for leveraging the institutional competence
of management strategies to expand pharmaceutical businesses.
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Limitations
Limitations are weaknesses of the research (Podsakoff et al., 2012). Participants
in this study were from a scientific background with professional management positions
in the pharmaceutical industry; therefore, there is a possibility of misinterpretation of the
questions with administrative or business nature. The conceptual research framework
includes the research parameters and might not include all reflections of participants’
responses to the interview questions. The small sample size may make it difficult to
generalize the findings (Yin, 2014).
Qualitative research methods include limitations by the nature of the study that
includes researcher explorations of the meanings but not exact experimental designs of
participants’ practices and performances (Ercikan & Roth, 2014). In this qualitative
research study, the exploratory nature implied the limitation of the number of participants
from implementation perceptions of expansion strategy. Further limitations included the
participants’understandingsoftheprocessesandproceduresthattheyperformtoachieve
the strategies for expansion within the routine day-to-day tasks. Therefore, I defined in
the analysis part the different processes and procedures for contributions to the expansion
strategies and daily performance tasks, which was limited for each company practices
according to the perceptions and understandings of the participants and my
interpretations of the meanings. I used the keywords in context (KWIC) method to
minimize possible inaccurate interpretations (Leech & Onwuegbuzie, 2008). In addition,
I applied the member-checking process to confirm my interpretation of the meanings
from the participants’ answers.
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Delimitations
The scope of this study included Jordanian pharmaceutical companies.
Delimitations are areas that are not included in the research objectives (Rusly, Corner, &
Sun, 2012). My research targeted participants from Jordan only. I requested participants
with managerial experiences of 5 years and more. Therefore, I did not include managers
with less than 5 years in positions. The scope of this study focused on the accumulated
knowledge, experiences, training, and directives among leaders and managers in the
Jordanian pharmaceutical industry.
Significance of the Study
Strategic business expansion for industrial organizations is one of the growth
factors that stakeholders must address to increase interests in supporting organizational
changes and increasing financial benefits (Hofmann, Busse, Bode, & Henke, 2014). Ai
and Brockett (2012) recommended further research to explore strategic business models
that would develop organizational management awareness to advance business
expansion. In addition, shareholders and leaders are interested in promoting the social
changes that the company expansion strategies include through integrated sustainability
initiatives (Alakent & Ozer, 2014). I included the contribution of my study to business
practices and the implications for social change.
Contribution to Business Practice
Generic pharmaceutical leaders, managers, employees, and other stakeholders
could benefit frommystudy’sfindingsregarding successful capacity expansion
strategies. By applying effective expansion strategies for pharmaceutical products in the
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MENA region, leaders might increase the efficiencies and effectiveness of the business
models in terms of collaborations, investments, franchising, venturing, or mergers (Ai &
Brockett, 2012). Such business models for expansion strategies are long-term profit
generating practices, which include strengthening branding strategies, targeting new
markets, and increasing sales.
Implications for Social Change
Social changes are ideas, structures, and practices that involve institutional
developments for individuals or groups in an intersocial environment (Ney & Beckmann,
2014). In the MENA region, the demands for medication availability are increasing with
the rise of population, poverty, and prevalent diseases. In 2013, generic pharmaceutical
producers could not satisfy the demands of $26.2 billion worth of essential medicines
(UN Millennium Development Goals, 2014). Franks et al. (2014) recognized expansion
strategies with indication of corporate-cultural social change initiatives as an
advancement of corporate sustainability. I expect that my findings will provide generic
pharmaceutical leaders and managers with increased capabilities for catalyzing beneficial
social changes via capacity expansion strategies. The subsequent expansion could
provide adequate, affordable, and accessible medications for effecting social change by
fighting diseases in the remote MENA societies.
A Review of the Professional and Academic Literature
The exploration of the expansion strategy in this study includes the leadership
value creation to motivate followers and enhance performances. Therefore, the
transformational leadership theory of Burns (1978) was a foundation for this literature
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review, which I included in the conceptual framework in this study. In this review, I
included studies in which authors addressed relationships, explorations, and revisions for
the transformational leadership theory in the expansion strategies implementation. In
addition, I reviewed published works in pharmaceutical business fields that included
transformational leadership theory.
Stakeholder’stheorywas the second foundation of this literature review with
relation to the conceptual frameworkofthisstudy.TheapplicationofFreeman’s(2010)
concept of stakeholders included beneficiaries from expansion strategy. I related studies
in this literature review for the expansion strategy that authors addressed to explore,
quantify, and revise about stakeholders in the business expansion strategies. I reviewed
the literature for the expansion strategies in the concepts of transformational leadership
theoryandthestakeholder’stheoryfrompharmaceuticalpublishedbusinessworks.
Pharmaceutical leader awareness of expansion strategy benefits and requirements
includedevelopmentanddirectionofmanagements’effortsto
implement commercialization processes including marketing and sales (Moors, Cohen,
& Schellekens, 2014; Sarkees, Hulland, & Chatterjee, 2014). Stakeholders, including
the shareholders, mustbenefitfromthepharmaceuticalorganizations’business
expansion performance, which enhances leadership direction and improves
managerial understandingofthestakeholders’influence (Kazadi et al., 2015).
The purpose of this qualitative descriptive multiple case study was to explore
the effective implementation of expansion strategies that managers in
pharmaceutical industries in Jordan applied and the effective leadership strategy delivery
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for a profitable business. These research findings may add or assist leadership’s
perceptions to improve expansion strategy accomplishments. In addition, the findings
might identify the business value of the commercialization of the organization systems,
product sales, and effective business models between Jordan and other emerging
economies. This section includes a review of the professional and academic literature and
previously completed works related to the research topic. The discussion covers the
works that contributed to the conceptual framework: (a) leadership and business
competitiveness, (b) managers’toolstoachieveexpansionstrategies,(c)stakeholdersand
organization performances, (d) active and potential stakeholders, (e) organizational
systems relations in pharmaceutical industries, and (f) business expansion models in
pharmaceutical industries. Figure 1 illustrates the flow of the literature review for this
study.
Stakeholders

Transformational Leadership

Leadership and
Business
Competitiveness

Managers
and
Expansion
Strategy

Organizational
Management
Relations in
Pharmaceutical
Industries

Figure 1. Flow of the literature review.

Stakeholders
and
Organization’s
Performance

Active
and
Potential
Stakeholders

Business
Expansion
Models in
Pharmaceutical
Industries

16
For this literature review, I collected studies from Walden University’slibrary
database, related articles for expansion strategy, books, and web-based articles from the
Mendeley Desktop database with Zotero synchronization. In addition, I collected web
pages and websites from world organizations, pharmaceutical associations, and national
health organizations. I considered the contents for the topic and organized the materials. I
searched the articles within the databases to find alignment between the conceptual
framework and the problem statement and used the most relevant articles for citations. I
cited 278 articles, of which 257 (i.e., 92%) were from peer-reviewed sources published
between 2012 and 2016. I developed the literature review using 168 articles. In this
literature review, I used 156 citations from peer-reviewed articles published within 5
years from 2016, which is 93% of the total cited articles in the literature review.
Leadership and Business Competitiveness
Leaders leveraged the competitive business advantages by maximizing the
conversion value, lowering the costs, being the first to serve the markets, and increasing
the customer care efficiencies (Bartlett & Ghoshal, 2013). These processes improved
informationflowsandapplicationtocreatethefocusonthestakeholders’values
leveraging. Such values secure the sustainability of the organization and provide the
strategic competitive advantage, which include human resources ofmanagers’
competence as a fundamental factor for advancement (Bartlett & Ghoshal, 2013).
Leaders of the strategic intent thinking values, visualizethestakeholders’valuesand
create the satisfaction with innovative strategic plans to improve, maintain, and gain the
benefit in a long-term sustainable manner, particularly in the competitive markets
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(Bianchi, Chiaroni, Chiesa, & Frattini, 2011; García-Morales, Matías-Reche, & VerdúJover, 2011; Sharabati et al., 2010).
The leaders of the organization deliver the long-term requirements that fulfill the
vision, mission, and values to the lower managerial levels of the organization for
implementation. The transfer for implementation is the short-term planning,
implementations, and control, which are the management’s responsibility that manifests
the understanding of the enterprise level strategy (Elving, Westhoff, Meeusen, &
Schoonderbeek, 2012). The complexity of information and the level of the uncertainty
determine the efficient strategy streamline performances, in which complex information
and high uncertainty require effective enterprise-level strategy implementation
(Montalban & Sakinç, 2013). The transformation of complexity and uncertainty is the
managers’responsibilitytocreateworkable strategy levels for corporate, business, and
functional levels that deal with more confirmed information and certain processes and
procedures (Andries, Debackere, & van Looy, 2013).
Enterprise-level strategy procedures are the expandable view of the organization
that identifies the purpose of the foundation to generates public policies, and guides the
corporate level to lead strategy implementation in multiple organizational activities with
social and nonsocial preselected stakeholders values (Ditlev-Simonsen & Wenstøp,
2013). Enterprise level strategy formulators combine the intent thinking and purpose of
the formation to deliver the vision, mission, and value statements (Khanagha, Volberda,
& Oshri, 2014). Strategy statements include joining and mixing initiatives to convey
social, ethical, and legal codes of conduct that reflect the level of social responsibility
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application (Hahn & Lülfs, 2013). Stakeholders enforce sublevels of the strategy
implementation for actions and benefits of the organization long-term existence for
continuous markets’competitiveadvantages(Teixeira&Werther,2013).Thesublevel
strategies include the conversion of the enterprise-level strategy into procedural
objectives, targets, actions, initiatives, and processes (Beamish & Lupton, 2016). These
levelsareconveyorsfortheemployees’valuesinorganizationsthatcombine the
intellectualities, creativity, and innovations for the advancement of the daily
performances that reflect the stakeholders’ values (Xu, Zhang, & Ma, 2013).
Leadership style is a critical factor in delivering objectives, creating awareness,
motivating management, and controlling strategies implementations (Matzler, Strobl, &
Bailom, 2016). Simoes and Esposito (2014) found improvement in resistance to change
between management and leadership because of effective communication that leaders
practiced during the change process. Effective communication between leaders and
strategy implementers is critical to enhance competitive advantage and maintain a healthy
business climate. Therefore, the introduction of change management that leaders aim to
achieve duringexpansionsandbusinessdevelopmentincludemanagements’motivations
and awareness of theorganizations’values recognition among strategy implementers
(Fugate, 2012).
Transformational leadership style is dealing with change management that leaders
apply to leverage mutual benefits between leaders and followers through morality and
motivations (Northouse, 2013). The introduction of change management includes
transformational communication styles for information sharing among enterprise levels,
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in which employees are the primary factors in introducing effective changes (Ahmad et
al., 2014). Ahmad et al. found that through effective knowledge and sharing systems,
companies can obtain better communication between management and employees to help
achieve strategy tasks, which requires improvements in organizational culture, motivation
method, organizational structure, and employee perception to increase the knowledge
sharing positively. Therefore, transformational leadership is an effective leadership style
that supports change management with mutual acceptance between employees and
management.
Management and employee acceptance during change management introductions
is important for effective performance. Aalbers, Dolfsma, and Koppius (2013) studied the
connectedness and interunit ties during change management processes, and they found a
significant relationship between transformational leadership style and employees’
connectedness. The trustworthiness of the transformational leadership included
information and knowledge flow for the appropriate benefits that stakeholders need to
implement and support changes (Akhavan & Pezeshkan, 2014). On the other hand,
Kottke, Pelletier, and Agars (2013) found employees with no confidence in leadership
wouldnotacceptleadership’sideas,whichresulted in low scores on employees’
performance and employees tended to sabotage leadership strategy; in addition, conflict
ofinterestwasacauseforemployees’lack of confidence in leadership. Therefore,
acceptance of change is a generation of leadership style and follower perceptions that
include mutual understanding and benefits.
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Motivation is a transformational leadershiptooltoleveragefollowers’perceptions
that differentiated leaders and employees performances across organizations (Li,
Sheldon, & Liu, 2015). Leaders need to practice the best intrinsic and extrinsic
motivation to develop perceptions and leverage performances, which includ leaders’
understandingsoftheemployees’motives(Benedetti,Diefendorff,Gabriel,&Chandler,
2015). Employees work because of personal benefits and interests, are employees with
intrinsic motivation. Similarly, employees working for external affecting incentives or
rewards are with extrinsic motivation behavior (Yoon, Sung, & Choi, 2015). Cerasoli,
Nicklin, and Ford (2014) examined the relationship between intrinsic and extrinsic
employees’motivations;andemployees’performances, which indicated positive quality
performance due to intrinsic motivation and positive quantity performance due to
extrinsic motivation. Knowing the motivation drivers for employees is primitive for
transformational leadership.
Successful implementation of tasks is another motivating factor for employees
thatleadersneedtoevaluateandreward(Butt,Shafi,&Malik,2015).Employees’
motives and behavioral factors affecting performances are critical information for leaders
for assigning tasks, introducing changes, or promoting initiatives (Lamm, Tosti-Kharas,
& King, 2015). Expansion strategy is a challenging strategy for leaders introducing
changes in organizations, in which employees will need adequate orientations,
involvements, and task clarifications to evaluate results and maintain motivations (Dobni
& Klassen, 2015). Therefore, transformational leadership style includes talent
management and identification for alignment with core business advancements and
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functionalactivities’performancesduring change management processes (Joyce &
Slocum, 2012).
Leaders in expansion strategy require the motivational talent for followers to
implement strategy initiatives. Hirsch (2014) reported the transformational leadership
effectiveness because of the cultural understandings, following performances, updating
for achievements, and communicating effective practices that motivated workers.
Rewards, recognition, and job satisfactions are additional characteristics for leaders to
apply for change management, in which monetary reward is essential for different levels
of organization (Malik, Butt, & Choi, 2015). Leadership encouragements and motivations
includeemployees’engagementsinsharingchangemanagementbenefitsandvaluing
performances (Güntert, 2015). Therefore, transformational leadership is engaging
employees for practicing changes and benefiting in a motivational environment that
enhances development and competitive advantages.
Expansion strategy in organizations is a requirement development process that
includes innovation and creativity. Transformational leadership style is a practice for
initiations and support of innovation and creativity, which is a critical change for
competitive advantage (Schriber & Löwstedt, 2015). Burgess (2013) found critical
communication style relationship between management and leader’s decision maker,
which formed advancements due to sharing and engaging of strategy implementers in
decision making processes for the organization. Transformational leaders apply
engagement practices that the communication, trust, motivation, and awareness are
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functional processes for developing mutual understandings for the sustainable
organization in competitive business markets (Men, 2014).
The competitive edge of organizations in a market environment is critical for
developing the image and enhances performances, which leadership style determined by
changeintroduction(Gotsis&Grimani,2015).Knowingthesubordinates’capacitiesand
competencies are essential for leaders’ assignments for employees and managers that
includeevaluationfordevelopmentrequirementandexpectations’measurements(Wallo,
Ellström, & Kock, 2013). In addition, leadership critical thinking is a further competence
for leaders to evaluate, expect, and controlperformancesthatattainabletarget’s
capability of subordinates for the desired level of performances generates the competitive
edge in the markets (Howard, Tang, & Jill Austin, 2015). Therefore, leadership business
capacity and management performance are characteristics of organizations with a
competitive edge in business environments.
In addition to leadership business competency, leaders need acceptable behavioral
charactersthatsubordinatesappreciateincludingethicalbehavioraffectingemployees’
perceptions and performances (Xu, Loi, & Ngo, 2014). Demirtas and Akdogan (2015)
found leaders toinfluencemanagements’andemployees’behaviorsbecauseofthe
leaders’charactersthatfollowersacceptedfromethicalbelieveinleadership.Walloetal.
(2013) found leaders with more administrative involvements less effective in
development orientation of the organization and found leaders with higher development
orientation are influencers for learning orientations in the organization. The leadership
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charactersandinfluencesarecriticalfactorsthatdeterminetransformationalleaders’
effectiveness in development and learning.
Transformational leadership style includes work enhancement, learning
orientation, and encouragement for development at all organizational levels (Dubey,
Gunasekaran, & Samar Ali, 2015). Dubey et al. examined leadership relationship
management between managers internally and external entities, which is critical for
organization’sadvancement.Suchrelationshipsare the result of leadership learning
orientationandperformances’preferencesthattheleadersapply in companies (Dubey et
al., 2015). Rewarding employees for completed achievements is the transactional
leadership style that employees require, but satisfied employees appreciated more
transformational leadership style for learning and development (Deichmann & Stam,
2015). Deichmann and Stam found committed and motivated employees to realize
acceptance of new ideas by leaders as an effective factor for transformational leadership
style. Transactional and transformational leaderships are dealing with motivating
followersusingdifferentapproachesdependingonfollowers’perceptions,values,
cultures, competencies, and needs (Eisenbeiß & Brodbeck, 2014).
Leaders’ understandings of followers are significant in decision makingpractices
that leaders need to introduce changes and leverage performance (Kottke et al., 2013).
Leaders must acquire the businessaswellasbehavioralinfluencestodevelopfollowers’
knowledge that target the learning processes in the organizations to the advancement and
competitiveness (Epitropaki, Sy, Martin, Tram-Quon, & Topakas, 2013). Competent
leaders can forward influences in the organizational structure that the business
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environment is changing because of external factors affecting organization performances
(Parnell, Lester, Long, & Köseoglu, 2012). Leaders in such conditions are the finders of
therequiredeffectiveperformancesthatmaintainorganizations’existence,particularly
during a crisis or changing regulations (Petrou, Demerouti, & Häfner, 2015).
Pharmaceutical companies are examples of leadership resilience in the changing
business and regulations environment because of new discoveries, financial crises,
generic introductions, intellectual property rights restrictions, good manufacturing
practices (GMPs) development, and increased the cost of innovation and development
(Fisher, Cottingham, & Kalbaugh, 2015). Leadership style, orientation, knowledge,
encouragement, and motivation are fundamentals for pharmaceutical companies to
maintain competitiveness and existences, which contribute to innovative business models
(Aslam, 2015). Such business models are introductory to mergers, acquisitions, licensing,
technology transfer, franchise, innovation outsourcing, and products development
(Michelino, Lamberti, Cammarano, & Caputo, 2015; Nishimura & Okada, 2014;
Srivastava & Prakash, 2014; Wang & Li-Ying, 2014). Therefore, transformational
leadership for pharmaceutical industries is an appropriate style to maintain a competitive
business edge.
Managers and Expansion Strategy
Transferring organization vision to strategy actions is the leaders’ responsibility,
while business strategy implementation is the responsibility of managers and leaders’
subordinates (Saini & Sengupta, 2016). Strategy implementation includes competent
managers with effective performances that activate procedures and methods for leaders
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desired visionary achievement (Joyce & Slocum, 2012). Therefore, effective strategy
implementation is determinant of the management capacities and leadership style
effectiveness.
Management qualifications in business development are fundamental to achieve
the expansion strategies for organizations (Davies, 2013). Davies discussed the inter
firms deals and the third business party involvement in the international pharmaceutical
transactions. Davies found the process dependent on the business development and
licensingteams’negotiation,management,knowledge,andprofessionalqualifications
that accounted for mutual benefits for the parties involved. Osabutey and Debrah (2012)
foundgapsinmanagements’qualificationsforimplementingprofessionalexpansion
processes between the expertise owners and the transferee party and recommended for
inclusions of requirements for effective policies in organizations to develop the
technology for the acquiring party. Therefore, certain business processes in the strategy
implementationaresusceptibletodeclineordisruptbecauseofmanagers’competencies.
Leaders in strategy implementation must account for realistic activation of
procedures and methods for execution bysubordinates’evaluationsfor a capacity
requirement or sufficiency (Beck & Wiersema, 2013; Sharda, 2012). Such evaluation
includes indications for management evaluation of strategy implementation and levels of
understandingsoforganizations’missionsandvalues(Cantamessa&Montagna,2016).
The strategy implementers are the primary working factors for achieving targets and
activate procedures.Managers’perceptionsof expansion strategy are important for
effective implementation of the requirements that integrate the organization's resources
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andproceduralchange’sintroduction(Cantamessa&Montagna,2016).Bowen,Baker,
and Powell (2015) studied the managerial perception due to the effect of globalization on
the strategic decision that managers applied for expansion strategy. Bowen et al. found a
significant positive relationshipbetweenmanagers’perceptions and completed expansion
strategy requirements. Therefore, leaders’ awareness aboutthemanager’sstrategy
implementationcapacityiscriticalforeffectiveexpansionchanges’requirements.
Expansion strategy implementation is a process for including updates and
introduction of developments totheorganization’ssystem.Thebusinessmodelsthatthe
organizations select for the expansion strategy vary depending on the strategy, internal
productivity capacities, human resources, external business environment, cultural values,
and regulatory enforcements (Bowen et al., 2015; Pak, Ra, & Lee, 2015; Patel, 2014;
Srivastava & Prakash, 2014; Tantash, 2012). Managers during the strategy
implementation stages must define the objectives of the strategy and prioritize the
activities with an alignment that include multiple internal systems in the organization
(Hirsch, 2014; Mastorakis & Siskos, 2016; Parnell et al., 2012). Integration and
alignment are critical for new systems inclusion in the organizations, which leaders must
visualize, follow, communicate, and evaluate (Simoes & Esposito, 2014). Leaders
measure the effectiveness of the expansion strategy implementation by the model
business workability and returns on investment (Dubey et al., 2015), which is the result
of aligning capacities and integrating efforts.
The leaders focus must include appointing capable managers for the expansion
strategy in the right strategy task, in which managers align the effect of the
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implementation of the strategy and organization objectives actively (Akhavan &
Pezeshkan, 2014). Managers as strategy implementers need to understand the actions and
initiatives that link organization values, cultures, and objectives for better performance in
the strategy execution (Green, Albanese, Cafri, & Aarons, 2014). Friedrich von den
Eichen, Freiling, and Matzler (2015) discussed the reasons for failing business models,
which include management rejection due to (a) lackofmanagers’awareness,(b) lack of
defining proper research about the business model, (c) logic application, and (d) cultural
differences. Leaders’ knowledgeaboutthemanagers’stylesandthinking practices is a
requirement for the application of appointing managers for strategy implementation.
Managers’designthinkingandpracticalapplicationsareimportantfoundation for
expansion strategy implementation. Endenich, Hoffjan, Schlichting, and Trapp (2016)
studied factors affecting harmonization between expanded business units for
multinational companies with global presence. Endenich et al. (2016) found the
challenges for harmonization dependent on qualities of national market employees, GMP
regulations in the local market, and more important the management personalities in the
local market that communicate with other markets. McMillan and Overall (2016) argued
thatmanagers’flexibilityandawarenessarecriticalforsolvingstrategicproblemsduring
strategy implementation, which the changing market environment is creating. McMillan
andOverallpointedthattheseniormanagers’mindset,designingproblem solving
structures, and the performance system application are critical characteristics for the
managers in strategy implementation. Therefore, appointing managers for strategy
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implementation is a process that requires awareness ofthemanagers’capacityand
competency.
Transformational leadership is the leadership style that leaders apply to introduce
changes through motivations. Managers and subordinates personalities, awareness, and
culture alignment with organizational values is the leaders’ responsibility that introduces
the appropriate change for strategy implementation (Donate & Sánchez de Pablo, 2015).
Knowledge management practices that leaders apply in the organization motivate the
acceptance to adapt changes for strategy implementation (Ahmad et al., 2014). Abraham,
Morin, Renaud, Saulquin, and Soparnot (2013) found a significant relationship between
knowledgeexperts’expectationsfromapplyingchangesandeffectivemotivationsthat
leaders applied. Therefore, the motivational application that transformational leaders use
must address knowledge gaining about the changes and alignment requirement within the
cultural organization approach.
Transformationalleaders’knowledgeaboutthecultureofmanagersand
subordinates is important for the motivational application. Huhtala, Feldt, Hyvönen, and
Mauno (2012) studied the cultural effect on organizational goals implementation and
found a significant relationship between ethical organizational culture and organizational
goalsorientedsubordinates’desires,whichsupportedleadershipethical and cultural
applicationforbettermanagers’goals implementation. Aalbers et al. (2013) found
intrinsic and extrinsic motivation for managers to defer with the organizational cultural
during important processes implementation for organization advancement. Understanding
the culture, knowledge awareness, and motivational needs are the transformational
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leadership applications for change introduction that provide the organization with
competent managers for strategy implementation (Chan, Uy, Chernyshenko, Ho, & Sam,
2015; Guay, 2016). The competent managers are capable of solving problems,
communicating effectively, and tolerating cultural differences in the expansion strategy
implementation.
Internationalization is an expansion strategy objective that leaders deliver for
implementation to managers and subordinates (Hadjikhani, Hadjikhani, & Thilenius,
2014). Filiou and Golesorkhi (2014) discussed the importance of matching influential
abilities of the partnering organization executives in the expansion process and described
the levels of the advancements of the knowledge gain that contributed to successful
implementation of the expansion activities. Filiou and Golesorkhi suggested that the
global institutional framework influence the development of institutions at any level of
development. Similarly, Bellamy, Ghosh, and Hora (2014) related the internal
organizational changes requirement for development with the gaining from expansion
strategy that the partnering, outsourcing, regulatory attainment or knowledge sharing
imply during the process implementation. Therefore, awareness for adaptability is critical
for leaderships and management during the implementation of expansion strategy.
Pharmaceutical expansion strategy manager must adapt the regulatory
requirementforproducts’marketingauthorizationsinthetargeted countries (Civaner,
2012). The adaptation includes changes introduction that must align with the regulatory
requirement, which managers influence, adjust, implement, and control to satisfy the
regulatoryrequirements(Wrona&Trapczyński,2012).Yadav (2013) studied the
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processes that involved changing mechanisms to comply with standards for different
regulatory requirements based on the targeted markets. Yadav found multiple managerial
levels’involvementsthatneedbusiness,technical,andinvestment understanding to
accelerate the expansion strategy effectively, which depend on communication and
managementstylesintheorganization.Themanager’stechnicalcapacityandmanagerial
intelligence are critical in advancing the expansion strategy, which leaders must support
by leveraging the managerial understanding including technical competency (Wrona &
Trapczyński,2012).
Successful strategy implementation is a process that requires the utilization of
business, technical, and managerial competencies. Liang, Howard, Koh, and Leggat,
(2013)studiedthecriticalmanagers’competenciesthatmanagersmustacquiretodeliver
organization’sobjectives.Liangetal.(2013)accountedforinterpersonalcommunication
qualities,operations’resourcesmanagement,leadingchangemanagement,anddecision
makingmanagement as primary competencies for managers to achieve the strategy
objectives in organizations. Trong Tuan (2012) found a significant relationship between
managers’transformationalbehaviorandbusinesstargetseffectiveness,whichimprove
business outcomes and advance organization image. Managers in advancing business
effectiveness in organizations must combine technical and business qualification that
leveragethestakeholder’sinterestandattainbusinessprofitability(Miles,2012).In
addition, theorganization’sbusinessperformanceisastakeholder’sinterest,which
managers maintain for effective business expansion and sustainability.
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Stakeholders and Organization’s Performance
Commercial application of the business expansion models that the advanced
systems included formed intangible assets for the industry, which needs continuous
maintenance and funding by the shareholders as primary stakeholders of the
organizations (Esper et al., 2010; Guthrie, Ricceri, & Dumay, 2012). The strategy
formulators’objectivesincludethepredictionofthefuturepositioningofthe
organization'sstrategiesbyvisualizingtheinternalorganization’ssystemcapacitiesand
the external market environment elements (Chatterjee, Randour, & Raskin, 2014). The
practical implementation of the sustainable strategy includes defining the primary success
factors for the analysis of the prevailing environmental factors (Lindgren, 2012).
Lindgrenincludedthecapabilitiesoftheorganizationthatsatisfiedthecustomers’long
term loyalty as a sustainable strategy for implementation, in which the value chain of the
organization reflected sustainability. Focus approach is a successful way of identifying
the primary success factors for pharmaceutical companies, in which the strategy
formulators balance the internal resources and external demands to sustain the value
objectivesoftheenterprise’slong term existences (Tatham & Spens, 2011; Teirlinck &
Spithoven, 2013). Therefore, involving stakeholders in the expansion strategy is critical
fororganization’ssustainability.
Leaders in organizations are responsibleforstakeholders’adaptationto
organization’scompetitiveadvantages.VerbekeandTung(2013)proposed a framework
forvisualizingstakeholders’adaptabilityfromthetime of formation to the time of
development strategy that required expansion for heterogeneity sources of incomes.
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VerbekeandTung’sframeworkincluded a transformational application that practices
trust and effective communication with stakeholders for strategies formulations and
benefits awareness. The key element of the stakeholder theory is to establish a beneficial
relationship between business parties, which aims to generate an increase in wealth and
benefits (Talbot & Boiral, 2015). The beneficial relationship includes supportive
approach from stakeholders for the initiated changes in the organization that extended the
effective performances (Hernantes, Rich, Laugé, Labaka, & Sarriegi, 2013). The
extended performances are the results of the changing environment in the business, in
which the expansion strategy implementation involves for the benefit of the stakeholders.
Stakeholders are the directors of the organization activities and performances.
Freeman's (2010) definition of stakeholders depended on organizations’interactions
within the business environments, which include parties from internal and external
surroundings of the organization. Freeman extended the affected parties to include
governments, competitors, suppliers, employees and regulatory parties. The
organizations’activitiesinvolvechanges,benefits,anddevelopments,inwhichsocial
interactions consequences affected the organization's strategic performance (Miles,
2012). Freeman focused on the identification of the benefiting and affected parties or
individualsthatcontributedtoeffectivenessordeclinationoforganizations’
performances.
Stakeholders affect the organization performances because of the decision basis
that the stakeholders make for or against the organization. Decision makingtheory
included the views, opinions, ethics, and skills that the individuals gained, as the basis for
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formattingtheindividuals’decisions(Smith,2014).Stakeholder’sdecision making
processisaffectingtheorganizations’performancesbysupporting, advancing, or
declining the leaders’ decisions for changes or modifications that the current market
environment involves for competitive advantage (Hernantes et al., 2013). Paul (2014)
described the relationship between stakeholders as a critical influence on the decision
makingprocess, which effective communication and transparency with trust mitigate the
effectiveness of the organization in the competitive business environment. The
transformational effectiveness of the organization includes effective communication and
transparency that leaders, managers, employees, customers, and regulatory authorities
practice during the change management processes (Cui, Li, Meyer, & Li, 2015).
Therefore,transformationalleaderships’actionsandstakeholders’understandings, with
alignment, are critical for expanding business and gain competitive advantage.
Stakeholders’decisions may affect the resources allocation that organizational
leaders require for effective strategy implementation. Scheibehenne, Rieskamp, and
Wagenmakers (2013) provided theoretical framework using Bayesian inference technique
that uses beliefs and behaviors of individuals to determine the actions that individuals
make. Scheibehenne et al. (2013) indicated for the application of the model for the
expansion strategy, which could apply to the stakeholders as the primary influencers for
the organization resources facilitation to understand the forces driving the decision
makingprocesses. Such forces might not include monetary benefits only but extend to
social, environmental, and pride values that the supply chain management, investment,
and purchasing behaviors of stakeholders control the organization activities and
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expansion decisions for sustainable performances (Wolf, 2014). Therefore, knowing the
stakeholdersinfluencingneedsiscriticalfororganizations’leaders to implement the
expansion strategy effectively.
Wolf(2014)examinedtheexternalstakeholders’effectson the sustainable supply
chainmanagement’spracticesandfound a significant impact on ethical organizational
performanceonorganizations’strategiesonmarkets’expansions.Theexternalfactors
include forces that impact the organizational performances depending on the
understandings of the stakeholder and the affected benefits of the stakeholders (Balmer,
2013). Effective communication includes the right information delivery, at the right time,
and for the right people, in which employees, shareholders, investors, customers,
suppliers, and regulatory authorities need transparent information about the
organizations’activitiesandperformances(Martin, Miranda Lakshmi, & Prasanna
Venkatesan, 2014). Martin et al. (2014) found multiple levels of communication between
the organization and stakeholders that require effective analysis, which the decision
makers used for the organization competitive advantage. Therefore, transformational
stakeholder’seffectivenessdependsontheaccuratedataanalysisandinformation
communication that the organization strategy requires for the continuous support of
stakeholders to the expansion strategy implementation.
Expansion strategy implementers are the managers in the organization. These
managers convert the strategy initiative into monetary values that the stakeholders
evaluate as returns on investment (ROI), which is the primary key performance indicator
(KPI) for the leaders and managers in the organization (Vallejo & Wehn, 2016). The
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expansion strategy implementation includes ethical performances for ROI, in which the
unethical conduct cause adversely affected stakeholders (Hahn & Lülfs, 2013). Analytical
applicationofthestakeholders’valuesiscriticalfortheexpansionstrategytoindicatefor
the benefiting parties with supporting efforts for investments and controlling or avoiding
negatively affected parties within the organization activities (Öberseder, Schlegelmilch,
& Murphy, 2013). Therefore, managers in expansion strategy implementation must
acquire the stakeholders’valuesforeffectivestrategyimplementation.
Expansion strategy analysis includes identification of stakeholders for effective
strategyimplementation.Baker(2013)positedthatsocialorganization’seffecton ROI
generation as critical transformational value for communication with customers for
effective corporate social responsibility (CSR) practices, which customers needed
because of the evolved technological advancement. Prasad and Holzinger (2013) applied
extensive literature analysis research on marketing CSR practices and recommended
ethicaldistinctionbetweenmonetaryandsocialvaluesfordifferentstakeholders’benefits
including unknown stakeholders, which globalization included because of the
technological advancement, wide availability, and easiness of accessibility. Expansion
strategy implementation includes CSR practices for effective ROI that include active and
potentialstakeholdersformanagers’considerations.
Active and Potential Stakeholders
The dynamic business environment is a generation process of new involvements
of multiple parties. The parties’ effects on the organization performances include the
positive and negative influence of the organization activities depending on the benefits or
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riskthattheorganization’sperformances exert on the stakeholders (Arena & Arnaboldi,
2014). Customers, shareholders, employees, regulatory authorities, and society members
are the affectedpartiesoftheorganizations’performances,whichsimilarunanticipated
stakeholders from a potential for the organization if communicated effectively for
expansions activities interests (Mitchell, Van Buren, Greenwood, & Freeman, 2015).
Technological advancement and accessibility are one of the millennium globalization
tools for searching and defining interests that potential stakeholders apply to gain
knowledgeaboutorganizations’performances(Tsai&Bagozzi,2014).Mitchelletal.
(2015) found accounting stakeholders in the expansion strategy as critical communication
factor for the implementation that includes the expectations of the affected parties due to
the expansion activities. Therefore, defining stakeholders for the expansion strategy is
primitive for effective strategy implementation.
Pharmaceuticalindustries’applicationsofexpansionstrategy include multiple
stakeholdersaccountingforeffectiveimplementation.WronaandTrapczyński(2012)
explored the factors affecting marketing expansion strategy for pharmaceutical
companiesandfoundtheinterdependenciesbetweenthestakeholders’tobe critical for
strategyimplementations.WronaandTrapczyńskipositedthatknowledgeabout
customers, marketing employees, regulatory authorities, and society members in the
targeted markets was a critical construct for developing appropriate entry and expansion
implementation,whichdependedonthemanagers’communication,confidence,and
previousexperiences.Alkhaledetal.(2014)examinedstudiesforinfluencingphysicians’
prescriptions by medical representatives, which included knowledge sharing among
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parties and preference selection. Alkhaled et al. recommended collaboration between
regulatory authority, industrial entities, patients, physicians, and communities to benefit
from the marketing processes and mitigate adverse effects that the influencing process
included. Therefore, accounting for stakeholders is critical for expansion strategy that
leaders and managers in pharmaceutical companies must practice for effective expansion
strategy implementation.
Theadvancedpharmaceuticalssystem’scommercialization enforced the
competitive advantages by identifying business expansion models for collaborating,
supplying, and servicing industries in different regions that integrate to accomplish tasks
(Mehralian, A. Nazari, Akhavan, & Reza Rasekh, 2014). Mahsud, Yukl, and Prussia
(2011) discussed the influence of the effective linkage between the human capitals that
industries required for innovation, strategy implementation, and competitive advantages
creation of the organizations including other available capital resources. Mahsud et al.
(2011) concluded that the human capital advantages were a valuable resource for the
organizations, which stakeholders viewed as leveraged value for the competitive
advantages to account for new opportunities. Therefore, accounting for internal human
capital capacity is significant for expansion strategy that stakeholders value as
advantageous for the organization performances.
Qualification and experience of human capital in expanding organization is an
important factor for stakeholders’ trustandappreciation.Theexpansionstrategysystems’
integrations and synchronizations must reflect the cybernetic advancements of the use of
the expansion strategies (Singh & Jayanti, 2013). The feedback processes and the
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communication integration support the synergy requirements in the organization to
harmonize the different efforts toward the objectives of leveraging the stakeholder's
values. Hinterhuber and Liozu (2012) suggested that marketers must educate customers
as potential stakeholders about the value added cost and motivate the willingness of the
customers to pay for that value. Hinterhuber and Liozu encouraged leaders in
organizations to keep evaluating strategies and the negotiation techniques for better
understanding of the customer value because customers are important stakeholders.
The strategic expanding of organizational relationships and interdependencies of
thebusinessenvironmentareenforcingorganizations’responsibilitiesinglobalmarkets,
in which human capital intelligence is an advancing factor for effective strategy
implementation (Sohrabi, Asari, & Hozoori, 2014). The extended relationships for the
expansion strategy are factors for creating the stakeholders of the organizations within the
internal and the external interdependencies (Mason & Simmons, 2014). The satisfaction
of the stakeholders of the organizations becomes an important factor for the sustainability
and competitiveness of the markets (Mehralian et al., 2014). Finding effective
relationship between the internal and external stakeholders is a determinant for expansion
strategy application and longevity effectiveness (Napolitano, Marino, & Ojala, 2015), in
which increasing the number of potential benefiting parties supports the expansion
strategy effectively (Ocasio & Radoynovska, 2016). Therefore, leaders and managers in
pharmaceutical industries must satisfy the demands of existing and expected stakeholders
for the expansion strategy.
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Organizational Management Relations in Pharmaceutical Industries
Pharmaceutical industries constitute of divers, integrate objective, and interactive
systems in complex changing business and scientific climate (Nagurney, Li, & Nagurney,
2013). The scientific nature of the pharmaceutical industries and knowledge base
formation including the high impact on the lives of the intended consumers guided the
internationalhealthcareorganizationstoregulatethepharmaceuticalcompanies’
activities through enforcing GMP (Frau, Font Pous, Luppino, & Conforti, 2010). These
regulationsareforcontrollingandinspectingthesystems’operationsasanintegralpart
of the market authorization requirements (Yadav, 2013).
The complexity of the pharmaceutical industries included the involvements of the
systems that contributed to the predictions of the expected expansions of marketing
competitiveness (Malerba & Orsenigo, 2015). These factors include the research and
development (R&D), engineering, quality systems, production, marketing, and human
resources (HR) integration for processes implementation (Gilsing, Nooteboom, &
Gilsing, 2004), which must comply with GMP regulations (Nguyen, Seoane-Vazquez,
Rodriguez-Monguio, & Montagne, 2013). Mehralian et al. (2013) studied the
contribution of the intangible and intellectual capitals of the pharmaceutical systems to
the advancement of strategies and discussed the importance of the collaborations’
requirements as a business expansion model of the internal systems. Mehralian et al.
included employees, managements, and CEOs qualifications and awareness as critical
factors for the developed systems and expansion requirements. Creating the alert for
rationalapplicationsofresources,connectingorganization’sobjectiveswithphysical
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enforcement requirements, and managing the future implications of operational activities
are critical factors for organizations to implement and to attain the sustainable
organizations’goals(Enkel&Heil,2014;Oerlemans,Knoben,&Pretorius,2013).These
key factors are measures of advancements, control, and effectiveness of the business
expansion models that the leaders select to apply for the expansion strategy.
Adding value by applying expansion strategy is the aim for business growth and
advancement.Stakeholders’viewsandapprovalsfortheexpansionstrategyaddedvalues
are critical for benefits acquirements and wealth generation, which determine the
effectivenessofcorporatesystems’integrations(Hallbäck&Gabrielsson,2013).The
selection between the different business expansion models is leaders’responsibilities,
which include the evaluation of internal deliver capacity and market absorption capacity
(Yang, Chen, & Wang, 2015). Rahman and Lambkin (2015) examined 45 business
mergers and acquisitions, as an expansion model, to investigate the relationship between
expansions intended model and added value resulted from the process. Rahman and
Lambkin found a significant relationship between cost reduction and increased ROI, but
the process included a reduction in marketing efficiency, which the authors indicated as
failure to increase sales that affected other business processes. Adding value processes
through expansion strategy is critical for business and requires a collaborative
understanding between managers and leaders to mitigate affected processes.
Pharmaceuticalbusinessmanagementforexpansionstrategy’simplementationis
a collaborative processbetweeninternalcompany’scomponentandexternalmarket’s
requirements. Campbell et al. (2015) suggested a comprehensive quality indicator for
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marketing authorization that includes business efficiencies for cost effective products,
factors for introducing products to market, patient and professional involvement, and
technology application. Campbell et al. aimed to validate the quality, transparency, and
regulation for effective application. The components included in Campbell et al. model is
results for internal collaboration among management parties in the company and the
intended expansion strategy for the regulation environment in the regulating country.
Nagurneyetal.(2013)examinedtheoutsourcingeffectonpharmaceutical’squalityand
cost, which included the collaboration among internal management of business and
quality department for the decision makingprocess of the expansion strategy. Therefore,
pharmaceutical manufacturing systems and business expansion strategy must integrate to
add value and improve sales achievements.
Pharmaceutical’sGMPregulationcomplianceandbusinessachievementare
managers’responsibilities. Pagani and Otto (2013) studied the complex system of
marketing medicines to propose a quantitative follow-up framework that can help
systems’managerstoachievetargets.Decision makingand adjustability to variations
depended onthemanagers’competency and understanding of the organizational system
involved in pharmaceutical product and market development (Pagani & Otto, 2013).
Collective decision makingprocess between competent managers facing marketing
turbulence achieved practical policy adaptation to leverage competitive business
advantages (Pagani & Otto, 2013). Sharda (2012) explained the detailed processes that
involvemappingmanagers’competenciesandtalentmanagementinapharmaceutical
company. The processes included the combination of knowledge, experience, and
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competence for business and technical qualification that the company leaders develop in
managers to achieve strategy targets (Sharda, 2012). Therefore, pharmaceutical
organizational systems and management responsibility must alignwiththemanagers’
competencies to develop competitive advantages for expansion strategy implementation.
Information flow between organizational components is critical in the corporate
pharmaceutical system. Pharmaceutical industries are scientific knowledge base
industriesthatincludescientificdiscoveries,marketpreferences,regions’demands,and
epidemics fighting within the business construct to achieve social and economic targets
(Belderbos, Gilsing, & Suzuki, 2015). Tierney, Hermina, and Walsh (2013) selected the
pharmaceutical landscape technology for their study as a technique that accommodates
dynamic changes within the technology set of radical changes in the industry. Tierney et
al. (2013) studied the road mapping efforts for the innovations that are increasingly
failing to meet the primary goals of technologies into the strategic process of firms,
regions, or industries. Tierney et al. concluded that techniques include a promise to
provide superior value to the strategic process of firms, industries, and regions seeking to
profitfrominnovationsbornofmorethanonetechnology.Therefore,organization’s
information flow system is critical in linking and delivering the knowledge between the
different components of collaboration and combination of talents, experience, and
effective implementation.
Combining information from different organization components is the leadership
and management responsibility that include information’ssystem design and organization
to achieve the competitive advantages (Qader et al., 2013). Qader et al. examined
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relationships between knowledge management and competitive advantages in
pharmaceutical firms. Qader et al. found managers practicing a combination of
knowledge management achieved higher levels of competitive advantage, which included
acquisition, dissemination, and responsiveness to knowledge. These practices must
include market orientation that engages customer and competitor. Wilson, Perepelkin,
Zhang, and Vachon (2014) investigated relationships between market orientation,
alliance orientation, and business performance in a biotechnology industry. Wilson et al.
(2014) found a significant relationship between market orientation and business
performance, which supported the existence of a mediation relationship. Wilson et al.
concluded that behavioral orientations toward customers, competitors, and business units
wereimportanttoincreasebusinessperformanceincludingmanagers’understandingsof
the sequential relationship between the market-oriented behavioral commitments, alliance
oriented activities, and business performance outcomes. Therefore, managers must pay
particular attention to alliance scanning, coordinating, and learning because these
activities improve business performance.
Practitioners’andscholars’studiesinpharmaceuticalindustriesincluded
innovationcompetenciesthatmanagers’applytoleverageedgeforcompetitive
advantages (Epitropaki et al., 2013; Hu, McNamara, & McLoughlin, 2014; Kim, 2014;
Montalban & Sakinç, 2013; Pollock, 2014). The innovation practices in pharmaceutical
industries included introductions of business models for expansion strategy to enhance
business effectiveness (Erden, Klang, Sydler, & von Krogh, 2014). Montalban and
Sakinç (2013) examined the effects of financialization and competition on productive
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models in pharmaceutical companies. Montalban and Sakinç found pharmaceutical
companies’adaptationsofblockbustermodelmaximizedshareholdervalue,which
included financialization, technical change, product market regulations, and market
competition. Montalban and Sakinç concluded that institutional investors are accelerators
fortransformationalbusinessmodelsthatmustalignwithmanagers’controlsand
practices during expansion strategy implementation as an effective business model for
competitive advantage. Therefore, selecting business expansion model for pharmaceutical
industriesmustalignwithmanagers’organizationalcompetencies,externalmarkets’
competitions,andstakeholders’demands.
Strategic Business Expansion Models in Pharmaceutical Industries
Scholars and practitioners provided different studies in business expansion
models fromthetimeoftheintroductionofthe“strategicintent”thatHamelandPrahalad
posited in 1989. Business expansion models are part of the corporation strategy for
growth and profit generation that leadersformulatebydependingonthecorporation’s
componentsandmanagers’motives,competences,understandings,andqualificationsto
achieve the strategy targets (Martin, 2014). Enterprise managerial levels are important
formulators of the appropriate expansion strategy and method of implementation, which
decision makingprocess involved (Chen, Liu, Ni, & Wu, 2015). Chen et al. (2015)
examined the relationship between strategic intent and external business factors affecting
expansion strategy. Chen et al. found a significant relationship between the variables and
posited that expansion strategy and decision makingprocesses must align with intentional
and organizational capacities to achieve successful expansion strategy implementation.
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Therefore, expansion strategy includes multiple factors of the decision makingprocess
that leaders and managers must acquire to select the appropriate expansion strategy
within or outside the business constructs of the organization.
Business expansion strategies are of different types and nature in the literature.
Scholars and practitioners collected evidences of expansion strategy that include (a)
products and markets concentration, (b) integration of existing processes or products to
add value, (c) diversification of products or services to gain opportunities, (d) cooperation
with competitors or new entities, and (e) internationalization that include new regional
markets in global view (Hoppner & Griffith, 2015). The following subsections include a
description of these expansion strategies types with emphasis on pharmaceutical
industries.
Concentration. Concentrationistheprocessofincreasingproducts’availability
in existing markets for current and potential customers (Mehta, Hasan Farooqui, &
Selvaraj,2016).Pharmaceuticalmarketingmanagers’aretheimplementersof the
concentrationstrategybycoordinatingoperationsproductivityandmarkets’demands,in
which concentration strategy would increase productivity with alignment between the
factoryandmarkets(Salih&Doll,2013).Therequirements’formanagers’collaboration
and effective communication is critical in implementing the concentration strategy.
Markets’demands,internal manufacturing capacities, and supply chain processes are
criticalfactorsfortheconcentrationstrategy,inwhichmanagers’applicationofagileand
effectivesupplyofproductsmustmatchtheproducts’demandsinthemarkets(Töytäri&
Rajala, 2015).
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The advantages of concentration strategy include strengthening business, cost
reduction, customer loyalty, and effective assets utilization (Mintz & Currim, 2013). In
pharmaceutical industries, concentration process is beneficial because products exist in
the market, known to customers, and no further registration costs needed. The expansion
strategy with concentration includes identification of potential customers, leveraging
competition, increasing marketing efforts, and aligning productivity to satisfy demands
(Mintz & Currim, 2013). These factors are applicable for expansion in markets with an
effectivebrandingstrategythatmarketingmanagersapplytoinfluenceproducts’
competitive advantages by developing trust and transparency in marketing mix
formulation (Helm & Gritsch, 2014). Therefore, the application of concentration strategy,
as an expansion strategy, is beneficial for organizations with known brands and capable
of responding to marketing efforts.
Integration. Integration is the strategy that includes combining application of
existing processes to serve existing customers through cross-functional teams focusing on
serving customers (Turkulainen & Ketokive, 2012). The integration strategy processes
include a high level of communication and information flow that leaders observe and
evaluate to convey appropriate performances to the expansion strategy. Expansion by
integration involves multiple organizational functions starting with the supply chain
management to business-to-business formulation (Kozlenkova, Hult, Lund, Mena, &
Kekec, 2015). Gligor, Esmark, and Holcomb (2015) found a significant relationship
between integration strategy and supply chain management for agile manufacturing that
managers required for cost reduction strategy during uncertain environmental
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turbulences. Similarly, Zhang, S. Pawar, Shah, and Mehta (2013) investigated the
relationship between evaluating outsourcers and managing outsourcing relationships in
the pharmaceutical industry based on the theory of dynamic capability. Zhang et al.
(2013) found pharmaceutical companies outsource to include integrated relationships
with high dynamic capabilities, which manufacturing industries must efficiently and
effectively evaluate and manage to deal with the challenges and risks associated with
strategic expansions. Integration for expansion strategy includes benefits for
organizations and stakeholders.
Expansion strategy by integration is beneficial for controlling distribution
channels and serving targeted customers. Patel (2014) studied the retail channel
expansions through the integration of marketing and technical assets in relation to
customers’perceptionandacceptance.Patelfoundfailuresonlevelsofintegration
created an imbalance on meeting customer preferences and adapting new market
acceptance. The integration between downstream and upstream supplies in
pharmaceutical industries is critical because of the regulated processes involved that
requires effective communication, trustworthiness, scientific presentations, and fast
respond (Valverde, 2013). Therefore, effective expansion strategy by integration must
include appropriate communication, transparent partnerships, and qualified strategy
implementers.
Diversification. Diversification in expansion strategy is the application of new
products, markets, or methods of the business that change or modify the business
intention purpose (Benito-Osorio, Guerras-Martín, & Zuñiga-Vicente, 2012). Scholars
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and practitioners studied the diversification process that leaders introduced in different
industries and services to evaluate the value added by the process (Benito-Osorio et al.,
2012).Boz,Yiğit,andAnil (2013) studied the difference between types of diversification
and performance values. Boz et al. (2013) found performance indicators increased in
single and dominant businesses with diversification. The authors concluded that
increased performance level resulted as diversification focused on the internal resources
more than environmental opportunities. The applicants of diversification must account
for the manufacturing development and capacities to leverage the values for the
expansion strategy that would satisfythestakeholders’intentions.
Diversification processes for expansion strategy are of different types in literature.
The introduction of a newproductlinewithintheorganizations’activitiesisadirective
for diversification concentration, which includes the acquirement of new technologies,
research and development, or investments (Sisodya & Johnson, 2014). For example,
pharmaceutical industries are developing new products for treatments and new
formulations for convenient uses, which the end users would value as a new change for
better convenience application (Barei, 2013). Similarly, mergers and acquisitions (M&A)
of different core businesses between organizations are diversifications that leaders aim to
gain markets share, competitive advantages, or cost reduction by developing new
business line or transform the existing lines (Rahman & Lambkin, 2015). Diversification
typesorprocesses’selectionsmustalignwiththeleadershiptransformationalintentions
andmanagers’acceptancetoimplement the expansion strategy.
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Srivastava and Prakash (2014) studied the determinant factors for the evidence of
value creation through international M&A activity. Srivastava and Prakash indicated that
the diversification through M&A strategy was a solution for problems of tacit knowledge
transferring, which lead to competitive advantages in the pharmaceutical industry and the
rise of R&D activity. The development of these factors was the result of expansion
strategythroughdiversificationthatservedproducts’ developmentsandnewproducts’
entries to the markets. Tripathy and Prajapati (2014) accounted for the benefits of
diversification through M&A, which includes the development of competitive
advantages; improve the value chain, new market entries, products’availabilities,and
localmarketservices’developments.Therefore,theexpansionstrategyisanadvantage
for the company because of developing the know-how of the organization to compete
internationally and better serve current customers.
Cooperation with competitors. Scholars and practitioners studied the expansion
strategies between competitors that lead for cooperation to gain added value and prevent
new entrants into the market (Liu, Kauffman, & Ma, 2015). The cooperation processes
between competitors included similarities with M&A but with defined formats that
maintained the structures of cooperating organizations (Hallbäck & Gabrielsson, 2013).
Joint ventures formation between competitors is an example of expansion strategy
through cooperation. Park, Vertinsky, and Becerra (2015) studied the effect of tacit and
explicit knowledge transfer from foreign parents on the performance of young and mature
international joint ventures (IJVs). Park et al. (2015) conducted a study to define the
relationship between IJV, knowledge transfer, and performance. The authors found that
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IJV age influenced the transfer of tacit knowledge positively while the transfer of explicit
knowledge declined. The authors found knowledge transferred to influence the
performance of both young and mature IJVs and the transfer of explicit knowledge
significantly affected mature IJVs performance. Therefore, the cooperation between
competitors is an expansion strategy that leaders apply to change and develop business in
competitive advantage.
Licensing-in, licensing-out, franchising, technology transfer, and know-how sales
are forms of expansion strategy through cooperation between competitors, which include
diversification and internationalization (Bosch-Sijtsema & Henriksson, 2014; Dant &
Grünhagen, 2014; Yildiz, 2013). Oh and Contractor (2014) positedthatcompanies’
leaders with practiced local cooperation between competitors implemented effective
cooperation with regional and international partners. Strategy implementation is a
dependent process on the understanding of the decision makingmanagers in the
cooperation progression and leaders updating, which is a critical setup for the strategy
choices that leaders must acquire and develop (Hennart & Slangen, 2015; Shaver, 2013).
Costandbenefitincludingmanagers’cognitiveapproachestoimplementing expansion
strategy or the decision makingprogression are important factors for the choices that
leaders need for selecting the appropriate expansion strategy for cooperation with
competitors (Hansen & Grunow, 2015; Lengnick-Hall, Lengnick-Hall, & Rigsbee, 2013).
Cooperation between competitors includes strategic alliance that leaders design to
increase benefits and gain competitive advantages within the same organization construct
or through the new formations (Leischnig, Geigenmueller, & Lohmann, 2014). Boden
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andYassiaPaul(2014)exploredreasonsforfirms’failurestoachievethecompetitive
advantages through alliances. Boden and Yassia Paul posited that alliance management is
arelationalactivitymorethantechnicalfunction.Theauthorsdefinedmanagers’skillsof
awareness, communication, and structural position affecting activity in the firm as critical
factors for alliance strategy implementation. Bérard and Perez (2014) studied the alliance
dynamics between competing pharmaceutical companies through the real options model.
BérardandPerez’sstudyincludedtheR&Dalliancesthatthecompanieswereapplying
to decrease uncertainty, increasing flexibility, gaining experiences, and knowledge
dynamics. Bérard and Perez developed a complex qualitative model for the system
dynamics and real options approach to understand the complexity and the dynamics
surrounding the opportunities and threats of strategic alliances between competitors
around an R&D project in pharmaceutical industries. The authors described the critical
role of the human factor behavior and understanding for the dynamics of the alliances
implementation. Bérard and Perez found that managers must align with the alliances
value-added and appreciate the value of the real option evolved from the alliances to
leverage the corporate benefits. Therefore, leaders must define the role of managers in
expansion strategy and the competency requirement to implement the process.
Internationalization. Internationalization is the expansion strategy that the
organizations’leadersdesignforexpandingactivitiesoutsidethenationalmarket’s
border to increase benefits and add value for stakeholders (Knight & Liesch, 2015).
Compliancewithinternationalmarkets’requirementsiscriticaltoachieve the expansion
strategy, which includes competitive pricing method, quality proves, and on-time
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delivery (Homburg, Vollmayr, & Hahn, 2014; Yadav, 2013). The internal capability of
the organization is a determinant of the internationalization implementation and the
choices for procedures to follow. The choices for internationalization include (a) deliver
products or services to new markets due to unavailability, (b) customizing products and
services, (c) selective global customer or product, or (c) a combination of all procedures
to gain the competitive advantage of internationalization (Hadjikhani et al., 2014).
Expansion strategies through internationalization are in various forms of the
literature. The commercial applications and transferring gained knowledge, know-how,
and R&D results are forms of intangible assets internationalization for pharmaceutical
industries (Esper et al., 2010; Guthrie et al., 2012). The advanced pharmaceutical
intangiblesystems’commercializations are forms of competitive advantages for
expansion of inter-technology transfer for developing industries in different regions
(Mehralian et al., 2014). Yadav (2013) studied the challenges faced for
internationalization of pharmaceuticals regarding managing regulatory requirements in
different international markets. Yadav performed the study to account for the
requirements of regulation in different markets. The author found the knowledge in plant
approval requirement in regulating country and product registration procedures are
critical to manage regulatory requirements. Therefore, internationalization is a dependent
strategyonreceivingparties’requirementsandexpandingorganization’stangible and
intangible capabilities.
Leaders andmanagers’engagementintheinternationalizationstrategyis
important for effective implementation. Dixit and Yadav (2015) explored the
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motivations, obstacles facings, and benefits perceptions of managers practicing
internationalization in early and advanced stages. Dixit and Yadav performed the study to
understand and analyze the Indian pharmaceutical firms that have knowledge on the early
phase of internationalization and to compare with early entrants. The authors found that
motives for internationalization were different including before and after
internationalization. The authors concluded that empowerment is important for managers
to fill the competency gaps in early internationalization. In addition, expansions in
stringently regulated markets were beneficial for organizations to prove trustworthiness
for local market reputations and facilitation of further expansions with
internationalization strategy.
Transition
In Section 1, I included the foundation for the study. Section 1, I described the
background of the problem; purpose and nature of the study, the research question, the
conceptual framework for the study, key terms definitions. I included a description of the
assumptions, limitations, and delimitations, and I mentioned the significance of the study.
In addition, Section 1 included a review of the related literature for the study in relation
to the conceptual framework and research topic. Section 2 includes the research project
design for the expansion strategy implementation in Jordanian pharmaceutical
companies; data collection technique and analysis; and reliability and validity of the
study. Section 3 includes the presentation of findings, application to professional practice,
the implication for social change, recommendation for action, and future study. I ended
Section 3 with the summary and conclusion.
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Section 2: The Project
In Section 1, I explained the problem statement. Implementing expansion
strategies in pharmaceutical companies includes leadership and stakeholder implications,
which I discussed in the literature review. Exploring the implementation of the expansion
strategies used in some Jordanian pharmaceutical companies may provide knowledge
about the factors and requirements for successful developments of expansion strategies.
The development requirement may provide organizations with the competitive
advantages of expanding activities for better performance. Aligning the internal
developments of the production capacities and management performances must include
theexternalmarkets’absorptivecapacityinthetargetmarkets,whichI explored in this
study.
I applied the project parameters for a qualitative method to suit the purpose of this
study. In Section 2, I address the study’s project, which includes subsections. The
subsections for this study are (a) the purpose statement, (b) role of the researchers, (c)
participants, (d) research method, (e) research design, and (f) population and sampling.
The subsections include the reliability and validity of this study and the data collection
instruments and techniques. Section 2 also includes the ethical research subsection for the
ethical presentation of the study.
Purpose Statement
The purpose of this qualitative descriptive multiple case study was to explore
effective application of expansion strategy among Jordanian pharmaceutical managers to
satisfy the demand in MENA markets. I interviewed four CEOs and eight managers from
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generic pharmaceutical companies in Jordan who practiced and succeeded in applying
expansion strategies in the MENA region. I selected participants purposely from
Jordanian pharmaceutical managers who were experienced in the professional application
of expansion strategies in MENA markets. In addition, I applied member checking and
document review to achieve the triangulation for the validity and reliability of the study
(Yin, 2014). My findings may improve knowledge and efficacy of strategies and
practices for expanding business in the MENA region to satisfy potential market
demands. The remote MENA communities lack adequate pharmaceutical supplies and
suffer from different diseases that the generic essential medicines supplies could help
resolve in communities (UN Millennium Development Goals, 2014). These communities
are potential stakeholders who could benefit by increasing generic medical supplies,
thereby meeting both physician and patient needs for increasing availability and
decreasing costs of generic pharmaceuticals to fight diseases.
Role of the Researcher
Qualitative researchers are the primary instruments for the research study and
must not reflect biases during the research, direct the research to the perceived
understandings,orcontroltheparticipants’willingness to participate (Ercikan & Roth,
2014). Yin (2014) providedevidenceofresearchskillsthateliminatedtheresearchers’
biases for the study by (a) relating the questions to the research topic, (b) focusing
interpretation, (c) predicting flexibility for unplanned happenings, and (d) addressing the
problem statement throughout the research study. I kept the focus on the problem

56
statement by aligning the research question and the interview questions. I focused on the
answers of the questions to interpret and analyze data according to the research problem.
My professional experiences include working in managerial levels of
pharmaceutical firms in Jordan and some MENA region companies. During this service, I
participated in interviewing, communicating, and reporting events for CEOs and boards.
Participants in this research are CEOs and managers from pharmaceutical companies in
Jordan, which match with my career path. Qualitative researchers must depend on the
datacollectionmorethanresearchers’interpretationorexperiences (Yin, 2014). My role
in data collection concentrated on the answers of the participants to the interview
questions. I included theCEOsinterviewstovalidatethemanagers’answersandmitigate
bias. Membercheckingisthemethodthatconfirmsparticipants’understandingsfromthe
researchers’interpretations(Harper&Cole,2012).Iused member checking to avoid bias
and confirm meanings. The research constructs for the case study design include
triangulation to validate the data collections and minimize bias (Yin, 2014).
Researchers must observe respect and include explanation of the study purpose,
protection, confidentiality, and risks included for participation in the study (U.S.
Department of Health, education & Welfare, 1979). Researchers following of the
Belmont protocol provided trustworthiness to the participants to maximize benefits for
participating research studies andminimizepotentialharmsofparticipants’perceptions
(U.S. Department of Health, education & Welfare, 1979). For each participant in this
study, I observed and provided respect by including and explaining the informed consent
form contents of voluntary participation. For each participant I treated the information
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provided ethically, in which I protected the identities to avoid any harm for them. I was
the only person to keep the records, data, and information for the participants in this
study and I coded the names and organizations to protect identity in a separate protected
sheet in my secured computer. I followed Belmont protocol and provided trustworthiness
to the participants to maximize benefits for participating in this study and minimize
potentialharmsofparticipants’perceptions.
Participants
Case study design is a qualitative design including the alignment of the research
purpose with the study participants (Patton, 2015). The selection of the study participants
to gain an insightful understanding of the event, setting, or plans requires a purposeful
sample, which was appropriate to collect maximum contextual data (Yin, 2014). Nag and
Gioia (2012) applied purposeful sampling for their inductive study to scan the top
management strategy alignment with the execution of changes that implied competitive
advantages. Bergman et al. (2016) selected 25 participants from seven healthcare setups
fortheirinterviewspurposefullytocharacterizetheclinicalpharmacists’inter
professional collaboration. Yin (2014) listed six possible methods for data sourcing in
case study design that included interviews, observations, participant-observation,
artifacts, documentations, and archival records. I applied semistructured interviews for
CEOs, conduct similar interviews with managers, and review documents to achieve
triangulation. I applied the member-checking process to validate the data collection in
Jordanian pharmaceutical companies. Similarly, I selected participants from the lenses of
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thestudy’sconceptualframeworkoftransformationalleadershipandstakeholders
theories, which is a triangulation that adds to the study validity (Yin, 2014)
Jordanian pharmaceutical companies that applied the expansion strategy in
MENA region are present in Jordan with headquarters in Amman, Naor, Sahab, AlQastal, and Al-Baqaa. To explore the implementation of the expansion strategy in the
MENA, I selected CEOs from four Jordanian companies and eight managers from the
same companies of the CEOs. The CEOs are the designers and the decision makers for
the implementation of the expansion strategy, and managers are the executives of the
strategy. I selected managers participants according to their (a) involvements in
expansion strategy in the MENA region, (b) role in implementing expansion strategy, and
(c) agreement to participate in this study (Irvine, Drew, & Sainsbury, 2012; Vogl, 2013).
There are 16 working pharmaceutical companies in Jordan, in which 10
companies’productsareavailableinexternalmarkets(“JAPM- Pharmaceutical
Industry,”2016). I selected four companies, which are implementing the expansion
strategy in the MENA region. I pooled participants from business developments, strategy,
sales,marketing,manufacturing,qualitysystems,finance,andsupplychaindepartments’
managersforthemanagers’interviews. I sent participants written details about the study
before conducting the interviews and discussed the study objectives to build working
relationship. In addition, all participants received a copy of the Informed Consent Form. I
informed participants that their involvement in this study is voluntary and confidential. I
notified the participants that they might withdraw from the study for any reason or not
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answer any question they might feel uncomfortable to respond according to the Informed
Consent Form.
I conducted the interviews after receiving Walden University Institutional Review
Board (IRB) approval for collecting data. I assured participants’protections as human
research subjects. I provided participants my certification to conduct research with human
subjects,whichIreceivedfromtheNationalInstituteofHealth“ProtectingHuman
ResearchParticipant”(seeAppendixA).
I provided codesforthecompany’sname,participants’name,andparticipants’
position to assure human subject protection, anonymity, and confidentiality. I protected
the data in softcopies with passwords and data in hard copies in a locked cabinet. I
prevented thirdpartyaccesstotherawdataoranalysiswithouttheparticipants’
knowledge and information.
Research Method and Design
This section includes the justification for the use of the research method and
research design. The justification included the research instruments, population, and
sampling protocol that I used in this study.
Research Method
Qualitative research methods are useful for researchers seeking an in-depth
understanding of events, skills, or plans; in which numerical data or variables
construction’srelationshipsareabsentorunclear(Patton,2015).Practitionerresearchers
and scholars apply the qualitative research methods to identify meanings and
understandings where quantifiable data measurements or examinations that align with
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hypotheses are not appropriate (Bevan, 2014). Therefore, insightful exploration for
collecting data to leverage understanding in contextual formats is not suitable for research
that deals with data measurements to examine relationships between hypotheses.
Yin(2014)notedtheimportanceofresearcher’sinteraction with the direct
environment of the participants to gain adequate understandings of the research problem.
Expansion strategies implementation is a complex process for pharmaceutical industries
that required the involvement of multiple managerial, scientific, regulatory, financial, and
marketingentitiesintheorganizationtoachievethestrategies’objectives(Bowen et al.,
2015; Mastorakis & Siskos, 2016; Srivastava & Prakash, 2014). The research question is
the aligning research factor for developing interview questions to ask in-depth, openended questions within the research method and the purpose of the study (Marshall &
Rossman, 2016).
Pharmaceutical business expansion strategy in companies involve different
complex approaches and mechanisms for research anddevelopment(R&D),products’
formulations, marketing positioning, human resources, supply chain management, and
regulation variation between targeted countries (Bergman et al., 2016; Cantner & Rake,
2014; Wu, 2013). Lack of standardized expansion strategy between companies is an
industry differentiation for competitive advantage and positioning (Sarkees et al., 2014;
Tsokanas & Fragouli, 2012). Measuring the values for the expansion strategy in lacking
standardized nature of the industry is a challenge for researchers seeking understandings
of the processes implementation. Therefore, the quantitative method included restrictions
for the application of the exploration nature of this study. I excluded the quantitative
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method application for this study, and I applied the qualitative method approach, which
was appropriate for the purpose of this study.
Research Design
Research design selection between qualitative method designs involves evaluation
of different designs applicability for the purpose of this study. Qualitative research
designs include ethnography, narrative, and phenomenological for focusing on culture,
ethnic, and lived experiences of participants (Denzin & Lincoln, 2011). I evaluated the
qualitative designs for ethnography, narrative, and phenomenological application in the
complex, dynamic, and variable environment of expansion strategy in pharmaceutical
industries, which are not appropriate for this study.
Ethnography is the design that required a study in ethnicities or cultures
(Williams, 2007) while the purpose of this study is to explore the successful
implementation of expansion strategy in pharmaceutical industries; therefore,
ethnography is not appropriate to construct for this study. Similarly, the narrative is the
design that involves one participant describing lived experiences or event (Denzin &
Lincoln, 2011). Narrative design is not appropriate for this study purpose because of the
need to explore more than one participant in different levels of involvement in the
expansion strategy implementation. Phenomenology is the qualitative design that
researchers apply to explore an event or phenomenon that affected participants uniformly
(Bevan, 2014). Although, phenomenology design might seem appropriate construct for
this study, the lack of a standardized method for expansion strategy in pharmaceutical
industryincludevariationsinparticipants’implementation,understanding,organization
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culture, production capacity, markets orientations, and product positioning. With these
variations, the expansion strategy might not be a phenomenon of experience among all
participants. In addition, because of intentional leadership application of the optional
expansion strategy selection (Mastorakis & Siskos, 2016), the process cannot be a
phenomenon. Therefore, phenomenology is not an appropriate design for this study.
Case study design is the qualitative design that includes open-ended interview
questionstoexploreparticipants’experiencedsituationsintheirworkingenvironment
and to identify the ideas of participants that answer the research question (Yin, 2014).
Case study design includestheresearchers’observations,semistructured interviews,
informal explanatory questions, and focus group selection tools for validating the
findings (Kaczynski, Salmona, & Smith, 2014; Parker, 2014). Theresearcher’sroleisto
translate the meanings or understandings oftheparticipants’responsestocodesand
themes (Collins & Cooper, 2014). The case study includes approaches for the
researchers, which extend the understandings through further informal exploratory
questions and further member checking to identify, assure, and characterize the core
concept that the participants experienced (Yin, 2014).
Expansion strategy implementation for pharmaceutical companies is not identical
and depends on multiple factors in the business environment (Horner, 2013). Case study
researchers apply single or multiple cases including the selection between explanatory,
descriptive, comparative, or holistic approaches, which is appropriate for the answering
the inductive research question and purpose (Cronin, 2014; De Massis & Kotlar, 2014;
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Miller & Tsang, 2011). In this study, the appropriate design for answering the research
question is the multiple descriptive case study design.
Population and Sampling
The population for this study included the leaders within Jordanian
pharmaceutical companies and the executive managers with successful expansion
strategy implementation. Yin (2014) posited the descriptive multiple case study design as
anappropriatesetupforresearcherswithparticipants’presencesinthesamesetting.
Researchers can select the best fitting sample for the case study design to collect data that
can reach saturation to validate the research design (Covell, Sidani, & Ritchie, 2012).
Samplingapplicationistheresearcher’sdecisionthatwill assure data saturation, in which
purposeful, snowball, or focus groups are applicable for census sampling method
(Robinson, 2014). I applied the purposeful sampling in this study because the purpose of
this study is to explore the effective application of the expansion strategy. The application
involved seniormanagementleaders’implementationsofthestrategyintheJordanian
pharmaceutical companies within the MENA region. Therefore, purposeful sampling is
an appropriate selection for this study.
The sample size for the exploration in qualitative studies is smaller than sample
size in quantitative studies (Marshall, Cardon, Poddar, & Fontenot, 2013). The purpose of
explorationistounderstandtheparticipants’experiencesfromthedatacollectedthatthe
researcher used from documents, interviews, direct observations, and participant
observations (Yin, 2014). Therefore, the small sample in case study design is appropriate
to answer the research question.
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I selected a sample size of four CEOs of senior management leaders from
Jordanian pharmaceutical companies because of their effective design and decision
makingprocess of the expansion strategy in the MENA region. I included a sample size
of eight senior managers from organizational development department, business and
strategy departments, operations and supply chain departments, licensing departments,
and marketing departments. The senior managers were from the same company of the
CEO that I Interviewed for each selected company. The CEOs and the senior managers
were from the Jordanian pharmaceutical companies, which was the population of this
study who are currently implementing the expansion strategy from Jordan through the
MENA region.
Participants must be in a current CEO and managerial position with more than 5
years practicing of strategy implementation. In addition, managers must have more than
two subordinates and a strategy for expansion in MENA region. I ensured that the
participants are eligible for this study requirement through signing the Informed Consent
Form.
I based the selection of participants on purposeful sampling. Walker (2012)
described purposeful sampling as an allowance for the researcher to sample a group of
people intentionally for the best information they can share to answer the research
question.Casestudyresearcherneedstoexploretheparticipants’perceptions;which
make purposeful sampling appropriate as no probability sampling technique (Richardson,
2009). I applied thesamplingfromthelensesofthestudy’sconceptualframeworkof
transformational leadership theory and stakeholder’s theory.
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Data saturation for the qualitative researcher is the point that the researcher will
not get new information from purposefully sampled participants; therefore, data
saturation is the determinant of the purposeful sample size (Walker, 2012). The
justification of the purposeful sample is important for the qualitative study to ensure
study validity and reliability (Yin, 2014). The appropriate sample size for case studies
can range from 5 to 50 participants that would allow the researcher to reach a saturation
point where no new information, no new theme emerged from participants and the
replication of the study would give the same results (Dworkin, 2012). I interviewed 4
CEOs and 8 senior managers from same Jordanian pharmaceutical companies of the
CEOs that experienced expansion strategy in the MENA region. I defined the data
saturation point afterconductingtheseventhparticipant’sinterview.
Interviews must include appropriate climate for participants to answer the
interview questions comfortably or propping questions without interruptions or
disturbance (Doody & Noonan, 2013). Researchers must provide participants the honest
and trust feeling including consent toanswerquestionsconfidentlyattheparticipants’
conveniences (Frels & Onwuegbuzie, 2013). I conducted the interviews at the
participants’conveniencesandincludetheInformed Consent Form before asking
questions.Conductinginterviewsattheparticipants’headquartersofficeswould reduce
traveling expenses and workplace leavings, which suits face-to-face interview and
participants’connivances(Wolgemuthetal.,2015). I requested participants to conduct
the interviews at their headquarter offices at their convenient time of the working day for
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about one hour to ensure no interruptions. Similarly, I requested another time for
conducting the member checking process with each participant.
Ethical Research
Human protection in scientific research is critical for the study creditability (Nah,
Bennett, Ingleton, & Savage, 2013). The protection of human subjects must include
protection from physiological, psychological, and any harm that might arise because of
participating in the study, which the international laws enforced for conducting research
with human subjects (Largent, 2016; Rivers & Lewis, 2014). Walden University
Institution Review Board (IRB) is the permitting board for conducting research. I
requested permission from IRB to conduct this study and to collect data from human
subjects as per Walden University requirements. For each site I selected to conduct this
study, I received permission from the CEO to allow conducting interviews. After granting
permission and receiving the Walden University approval number 09-13-16-0426476 in
the Informed Consent Form, I contacted IRB to approve conducting interviews with
participants. I applied the following steps:
1. I requested the CEO to participate in this study. I described the purpose of this
study and obtained permission to select managers from the same company to
participate in the study.
2. I requested the CEO to provide participants according to this study criterion
formanagers’participation.
3. I contacted each manager to describe the study purpose, ensure voluntary
participation, inform participants about ceasing interview at any time, and
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notify participants of the possibility to cancel an interview after
commencement.
4. I advised participants not to answer any question that they may feel
uncomfortable to answer.
5. I explained to each participant the identity protection and confidentiality
method I used in this study before conducting the interview.
6. I requested participants to sign the Informed Consent Form to ensure
participants’understandingsofthisstudypurpose and my role in this study.
7. I did notconductanyinterviewbeforetheIRBapprovalandparticipants’
signings of the Informed Consent Form.
I conducted theinterviewsintheparticipants’workplacesforobtaining
convenience and ensure low interruptions during the interviews. I requested approvals
from each participant to record the interview electronically using my laptop. I coded each
participant’scompany,position,anddateof the interview before saving the records
electronically. I used numbers and letters to code the recording and provided an
explanation for the coding in a secured file with password protection. I used multiple
letters,numbers,andlettercasefortherecordings’passwordsinthisstudy.
I protected all recordings using a password saved in my laptop with no access to
any party without my permission. I treated the raw data of the recording, transcripts,
identity of participants, and data analysis as confidential records, after completing the
data analysis, in a separate hard drive protected with password for 5 years from the date
completion of study. I will destruct the data by deleting files following the IRB
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requirements. I saved all hard copies in a locked cabinet. No party would be eligible to
access the raw data, analysis,identity,orhardcopieswithouttheparticipants’approval.I
provided no incentives for participating in this study.
Data Collection Instruments
Qualitative researchers apply open-ended question, interviews, or questioners to
collect in-depth dataabouttheparticipants’understandings(Yin,2014).Thisstudyisa
qualitative case study, in which I served as the instrument for data collection. Qualitative
researchers are the primary instruments for data collection because the researcher
prepares the study protocol, asks the interview questions, and records the answers for
analysis (Cleary, Horsfall, & Hayter, 2014). Semistructured interviews are appropriate to
collect qualitative data from participants that include an in-depth exploration of the
applied experiences of the research topic (Boblin, Ireland, Kirkpatrick, & Robertson,
2013).
The application of semistructured interviews is useful in case studies to provide
the researcher with projections to ask correlated researchers question (Yin, 2014). Condie
(2012)describedtheresearcher’sroleinretellingparticipant’sinformationduringthe
interview and asking clarification as an appropriate tool for more details about
participant’sexperiencesduringdatacollectionprocess. Salih and Doll (2013) used
semistructured interviews to ask in-depth questions about strategy implementation that
middle management practiced. Bergman et al. (2016) applied qualitative research to
study the role of pharmaceuticals in expansion and development of pharmacist-physician
communication using semistructured interviews. Yin (2014) presented for researchers the
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requirements for semistructured interviews, which included neutral conversation
guidance, preparing protocol, adherence to protocol, and prepare to follow up questions.
I used semistructured interviews in this study to explore the expansion strategy
implementation in Jordanian pharmaceutical companies. I asked participants to answer
open-ended questions and record interviews electronically. The questions list is in
Appendix B. My role as a researcher and data collection instrument was to ask questions
and further explanatory questions to collect data of the word-of-mouth that participants
related to theexpansionstrategy’sunderstanding.Iinterviewed 4 CEOs and 8 managers
who practiced expansion strategy implementation asking the interview questions for all
12 participants. For more clarificationoftheparticipants’responses,Iasked further
questions if I might find needs to explore more understanding from the participant. After
receiving the IRB approval number 09-13-16-0426476, I kept conducting interviews until
I reach to the data saturation point. I defined the data saturation point after conducting the
seventhparticipant’sinterview.
Qualitative researchers interview participants seeking data saturation for the
study’svalidity. Data saturation is the point where no more themes arise from the
interviews, participants repeat answers with no new information, or by repeating the
interviews using the same construct same results would appear (Fusch & Ness, 2015).
Walker (2012) posited that data saturation is important to ensure research data quality
and maintain credibility. Byrne, Brugha, Clarke, Lavelle, and McGarvey (2015) argued
that experienced, trained, and familiar researchers are capable of collecting quality data
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from peer interviews, in which researchers’ understandings and challenging supported
data adequacy.
I interviewed CEOs and managers from pharmaceutical industry who
implemented expansion strategy in MENA region. My profession in the pharmaceutical
industry was a tool that facilitated interpretationsofparticipants’answerstotheinterview
questions and allowed further clarification on the topic. The data saturation point of the
data collection in this study was after no new themes indicated from participants’
responses. Idefinedthedatasaturationpointafterconductingtheseventhparticipant’s
interview. I used member-checking technique to ensure that my interpretations match
withtheparticipants’understandingsoftheexpansionstrategyimplementation.
Data Collection Technique
I requested all participants to sign the Informed Consent Form before conducting
the interviews. For the CEOs, I phoned each CEO and ask for an appointment to conduct
the interview. Before the CEOs interview, I handed a printed copy of the interview
questions for each participant to review and decide voluntarily to conduct the interview.
The interview time ranged between 35 to 50 minutes. I requested the CEO to appoint 2 to
4 managers from the company to participate in this study and to provide their emails.
Accordingly, I sent emails of the question to the managers to review and prepare for the
interviews. I conducted theinterviewsinthecompany’sofficesformoreconvenienceof
the participants, and I requested no interruptions during the interview. I indicated for all
participants the privacy and confidentiality of the interviews.
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Conductinginterviewsintheparticipants’conveniencesisappropriateforgiving
a comfortableenvironmenttoexploreresearchquestion,saveparticipants’times,gather
observations, and enhance understanding (Allwood, 2012; Marshall & Rossman, 2016).
De Massis and Kotlar (2014) stressed for case study researchers to conduct interviews
with an emphasis on the conceptual framework for rigorous study findings, which must
guide the open-ended questions, observations, note taking, data collection, data analysis,
and interpretations. Recording interviews is a technique that qualitative researchers used
to take notes, view participants, and keep the interview track with the protocol (Jacob &
Furgerson, 2012).
Methodological triangulation is used in qualitative research to correlate multiple
datasourcesforrichdatacollectiontechnique,whichvalidatedthemesfindings(O’Reilly
& Parker, 2013). Member checking is an assurance of researcher interpretation of the
data collected, which adds to the study’svalidity (Yin, 2014). I applied the
methodological triangulation by conducting interviews with CEOs, interviewing
managers for the expansion strategy implemented in the company, and reviewing
documents. I asked CEOs form each company to provide the document for the
company’sfinancialstatementthatincludesprofitandloss,cashflow,andexpansions
achievements, which was the documentation data instrument for this study. I applied
member-checking methodology before data analysis process to confirm my analysis of
participants’responses. Case study researchers applied methodology triangulation
through collecting qualitative data from multiple interviews, observations, and
documents’reviews,orwebsites contents including member checking to collect rich data
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for rigorous design (Bekhet & Zauszniewski, 2012; Culpin & Scott, 2012; GonzálezFerrer & Peleg, 2015; Stephansen & Couldry, 2014).
Coding the recording for the interviews of each participant is an appropriate
method for maintaining confidentiality and anonymity (Gibson, Benson, & Brand, 2012).
I coded the recordings with alphabetic and numeric characters and verbatim each
interview manually from the recordings. The manual verbatim process is advantageous
because the researcher might gainmoreunderstandingofparticipants’repliesduringthe
verbatim but the process would take time for all participants (Page & McDonnell, 2015).
I applied the keywords in context (KWIC) to code the transcripts of theparticipants’
answers for this study. KWIC is an appropriate method for analyzing qualitative data and
form the coding of transcripts, which researchers need to understand meanings and assign
studies’themes(Onwuegbuzie, Leech, & Collins, 2012).
Data Organization Technique
Keeping raw data and data analysis organized is the responsibility of researcher,
which would support data retrieval and enhance credibility (Schermann et al., 2014).
Data organization includes assigning file names for stored data with noticeable
identification for references and content (Sayogo & Pardo, 2013; Wickham, 2014).
Qualitative data organization include videos, audios, notes taking, observations, and
documents, which imply proper data storage that would satisfy ethical, confidential, and
security requirements for human subjects protection (Largent, 2016).
In this study, I assigned alphabeticandnumericalfilenamesfortheinterviews’
recordings. The first character indicated for the site that I visited; the second character
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was numericalinserialfortheparticipants’interviews,andthethirdwas a character for
differentiating CEOs from managers. For example, A05C indicated for company A,
participant number five, and a CEO. I recorded interviews using HP laptop PC and store
the files in a specific folder for this study named study interviews with password
protection. The raw data storage served the data analysis, in which I used the coded
names for Mindjet program that I used. I maintained the electronic data storage, data
analysis, and electronic documents for the next 5 years from the date of the completion of
the study and CAO approval. Similarly, I stored printed materials of the raw data in a
locked cabinet for 5 years from the date of CAO approval.
Data Analysis
Data analysis is the method that qualitative researchers apply to obtain results for
the research problem using theories, conceptual framework, and appropriate qualitative
analysis techniques (Yin, 2014). Onwuegbuzie et al. (2012) provided multiple analytical
tools that researchers applied in qualitative research, which researchers aimed for quality,
credibility, validity, and reliability of the research. The qualitative data analysis includes
step-by-step manual data analysis formulation using conventional methodologies or
computer based programming that applied computer-assisted qualitative data analysis
software (CAQDAS) (Yin, 2014). Mind mapping is an analytical tool for qualitative data
analysis that researchers applied to identify themes within the conceptual framework of
the research (Webster et al., 2013).
I asked the interview questions (see Appendix B) and record the answers
including manual note taking during each interview. Transcription of the interviews was
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by manual re-play of the recording and typing of the answers. I requested participants to
speak in English if more comfortable to express understanding than Arabic. If Arabic
conversation evolved, I did not stop participants and keep recording. For Arabic answers,
conversation, or partial answers, I employed an authorized translator. The authorized
translator used my transcripts and coded recordings to approve translations. I collected all
English transcripts of each participant in Microsoft Excel spreadsheets. For each
question, I had re-written the answer and re-read the contents to be familiar with the text,
which qualitative researchers recommended for better understanding of the context within
the conceptual framework of the research (Lindberg, von Post, & Eriksson, 2013;
Onwuegbuzie et al., 2012; Webster et al., 2013).
Marking the keywords is appropriate for qualitative data analysis, which must
alignwiththeconceptualframeworkofthestudy(Baškarada,2014;Guest,Macqueen,&
Namey, 2012; Todorova, 2014). I used coloring text method (Dul & Hak, 2012) that
relatetotransformationalleadershipandstakeholdersintheparticipants’transcripts
answers within the Excel spreadsheets. I organized the coded text in adjacent columns to
the answers’texts and code the colored text of each answer based on transformational
leadership and stakeholder theories. I collected the codes in another column with
summaries from all answers. From the emerged columns of the codes, I identified
common themes and initiate a link, relationship, and connection between the themes.
Mind mapping technique is a tool for visualizing links, connections, and
relationships between the coded notes from the transcripts that qualitative researchers
applied for data analysis (Awad&Hegazy,2015;Balım,2013;Guerrero&Ramos,2015;
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Nakrem, Vinsnes, Harkless, Paulsen, & Seim, 2013). I used Mindjet software as a mind
mapping tool to group coded texts and themes from the Excel spreadsheets and connect
with labeling the relationships between the groups for each question and each participant.
I included in Appendix C the Mindjet map of the relationships between the themes from
the conceptual framework of this study. Webster et al. (2013) used Mindjet software to
connect the study-coded findings and arrange the themes for discussions. Similarly,
Nakrem et al. (2013) applied Mindjet software to connect relationships between coded
text and initiate themes for the research findings.
Categorizing, connecting, and comparing the codes fromparticipants’answers are
part of the qualitative analysis of the study findings, which includes rearrangement,
summarizing, filtering, and identifying major themes to confirm results (Bevan, 2014;
Onwuegbuzie et al., 2012; Yearworth & White, 2013). The emerging themes from the
data analysis are the sources for the study results that the researcher needed to confirm
findings by comparing, developing, or disclosing new themes by addressing other studies
and literature of the field of the research (Dadfar, Dahlgaard, Brege, & Arzaghi, 2014). I
analyzed the emerging themes from this study according to the literature review and the
conceptual framework. I compared the results with recent studies in expansion strategy
implementation and provided the reader a comparison between this study results and
other studies in the literature.
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Reliability and Validity
Reliability
Qualitative researchers prove the realistic and trustworthiness of the data collected
from real participants by addressing study reliability (Elo et al., 2014). The research
quality includes an emphasis on the data bias, which qualitative researchers address to
indicate for quality research (Marshall & Rossman, 2016). Yin (2014) determined the
setup for quality research for the case study design by triangulation, which included data
collection, methodology, or conceptual framework. I applied member checking and
documents’reviews methodological triangulation for the reliability of this study.
Member checking, as a construct of reliability, is the process that researchers
apply for the assurance about the interpretation of the participants’ answers to confirm
realistic and accurate interpretation of the raw data collected for the dependability of the
study (Marshall & Rossman, 2016). I applied member-checking procedure for this study.
After conducting the interview, I scheduled for another member checking time with each
participant andinformabouteachquestion’s interpretation. If my interpretation is not
similar to the participant’s understanding, I clarified the meanings and re-write the
interpretation.
Methodological triangulation is important for study reliability, which includes
different data sources to support the triangulation requirement for the dependability of the
study findings on the data analysis method employed (Denzin & Lincoln, 2011). I asked
thesamequestionintheinterviewsfororganizations’leaders (i.e.: 4 CEOs) and the
strategy implementers (i.e.: 8 managers) and reviewed the documents of the financial
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statements for each company, which were multiple sources of data collection for this
study. The analysis of the data in qualitative research includes and is a requirement for
the synthesis of the meanings that participants disseminated to add value to the
statements (Marshall & Rossman, 2016). I combined the analyzed codes from the
participants’answersandarrangein groups to collect the themes from the process, which
is a procedure to gain rich data and attain reliability (Yin, 2014). I followed the
procedural data analysis in this study with clear mentioning of the results at each step to
provide other interested readers details for re-analyzing to get same results. This
procedure included the dependability of the results on the methodology I employed for
this study.
Validity
Qualitative research validity is a confirmation of accuracy in conducting the
study, collecting data, analyzing data, and confirming findings (Houghton, Casey, Shaw,
& Murphy, 2013). Qualitative case study validity includes appropriate sample selection
for the study that confirms with the purpose of the study (Cronin, 2014). Validity in case
study design is a rigorous indicator for the researcher involvement in the data collection
and analysis that the researcher must provide for readers (Unluer, 2012).
I selected purposeful sample for this study from CEOs and managers with
expansion strategy implementation in Jordanian pharmaceutical companies, which
confirms with the validity of the case study through methodology triangulation for
confirmability. The purposeful sample is an appropriate selection to attain case study
confirmability requirement (Elo et al., 2014). I aligned the research question and the
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interview questionstoexploretheexpansionstrategyandremainfocusedonthestudy’s
purpose for better understanding, which confirms with credibility. I applied memberchecking procedureforaccurateinterpretationoftheparticipants’answers.Member
checking is a confirmation of the study validity that authenticates the intention of the
research and provides rigor construct for analysis (Vaismoradi, Turunen, & Bondas,
2013), which includes study credibility. I applied the member-checking process to
achieve the study credibility.
Data saturation is a validity construct of qualitative research, which confirms with
sampling application that will assure data saturation (Robinson, 2014). Data saturation
for the qualitative researcher is the point that the researcher will not get new information
from purposefully sampled participants; therefore, data saturation is the determinant of
the purposeful sample size (Walker, 2012). The justification of the purposeful sample is
important for the qualitative study to ensure study validity (Yin, 2014). I applied the data
saturation in this study. Data saturation point is the point that no new information
emerged, no new theme emerged from participants, and the replication of the study will
give the same results (Dworkin, 2012). After the seventh interview in this study, next
participants did not add new information or themes, which I considered as the data
saturation point for this study.
Transferability is a research validity that includes application in the different
construct of the site of the research, which indicates for generalization of the findings
depending on similarities or differences between sites (Duggleby & Williams, 2016).
Transferability in case study design is the application of findings in another context,
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whichisthereader’sresponsibilitytodetermine(Marshall,C.,&Rossman,2016).The
purpose of this study is applicable for Jordanian pharmaceutical companies with
expansion strategy implementation in MENA region. Therefore, I did not generalize the
findings to other contexts for this study.
Transition and Summary
The purpose of this qualitative descriptive multiple case study is to understand the
implementation of expansion strategy of Jordanian pharmaceutical companies in MENA
region by applying Yin (2014) construct and analysis of case study design. I used
semistructured and electronic recorded interviews to collect data to explore strategies and
participants’perceptions. I triangulated the data collection from multiple sources
including member-checking procedure to ensure study validity and reliability. I applied
purposeful sampling technique of professional pharmaceutical managers in Jordanian
companies, which practiced expansion strategy in MENA region. I requested from
WaldenUniversity’sIRBapprovalforconductingtheresearch, and I did not collect data
before obtaining IRB approval. I conducted face-to-face interviews with all participants,
record interviews electronically, and transcript verbatim of the recordings. I applied the
data analysis using KWIC method and follow the themes and patterns emergence for this
study.
In Section 2, I included and discussed the research methodology, study purpose,
role of the researcher, participants and sample size, research method and design, data
collection, and data analysis. I ended Section 2 with discussions for the validity and
reliability of the study. Section 3 includes the presentation of findings, application to
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professional practice, the implication for social change, recommendation for action, and
future study. I ended Section 3 with the summary and conclusion.
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Section 3: Application to Professional Practice and Implications for Change
Introduction
The purpose of this qualitative descriptive multiple case study was to explore
effective application of expansion strategy among Jordanian pharmaceutical managers to
satisfy the demand in the MENA markets. The specific business problem was that some
Jordanianpharmaceuticalcompanies’managers lack the effective application of
expansion strategy to satisfy the demand in the MENA markets. I applied a purposeful
sampling technique of 12 participants from professional pharmaceutical managers in
Jordanian companies, which practiced expansion strategy in MENA region.
The data collection method that I used in this study was face-to-face
semistructured interviews and financial statements review of each participant’s company.
Triangulation included transcript reviews of the recorded interviews and data from the
financial statements (Yin, 2014). I reached the data saturation point after receiving no
newthemefromtheparticipants’answers,which I found with the seventh participant in
this study. In Excel spreadsheets, I collectedtheparticipants’answersforeachquestion
and identified the keywords to code the context. By collecting the codes and the repeated
keywords from the answers, I identified the links between the questions numbers and the
answers using the Mindjet software as a mind mapping tool to group coded texts. The
emerged themes from this study were leader’s adaptability to change, financial capacity
and stability, stakeholders’ businessawareness,andmanagers’engagementand
knowledge. I received some recommendations from the participants that were related to
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the last question for sharing information about the effective application of the expansion
strategy in Jordanian pharmaceutical companies.
Presentation of the Findings
The overarching research question for this study was what strategies do Jordanian
pharmaceutical managers apply for effective business expansion to satisfy the demand in
MENA markets? The analysis of the data collected from the semistructured interviews
and the financial statements reviews included the identification of the findings to answer
the research question. I considered the data saturation, after I received repetitive
information from participants that could not add new information to the collected data. I
definedthedatasaturationpointafterconductingtheseventhparticipant’sinterview.The
findings from this study were the emerging four themes, which I related to the conceptual
framework for the transformational leadership and the stakeholders theory.
The maximum data collection was from the semistructured interviews with
participants. The second source of data was from the financial statements of the
participants’companies,whichI related to the cash flow and profit and loss statement.
After transcription of the interviews, I emailed participants the summary of the answers
including my interpretation to confirm with the member checking requirements of the
study design. After receiving the confirmation from participants, I applied the KWIC
processtodefinethecodesfromparticipants’answerstotheinterviewquestions. I
formed a mind mapping structure for the codes using the Mindjet program. By
connecting the codes from the answers and relating codes from different questions
including the financial statements codes, I defined the themes from the transformational
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leadership theory and stakeholders’theory.Thefourthemeswereleader’sadaptabilityto
change,financialcapacityandstability,stakeholders’businessawareness,andmanagers’
engagement and knowledge.
The first theme emerged in this study was the successfulleader’sadaptability to
change as a response to the turbulence of economics in the MENA region. The second
theme was the financial capacity and stability that shareholders andleaders apply to
successful implementation of the expansion strategy. The third theme was the different
stakeholders’businessawarenessofthepharmaceuticalindustryinMENA.Theforth
themewasabouttheimportanceofmanagers’engagements and knowledge about the
expansion strategy implementation. I aligned the four themes with the transformational
leadershiptheoryandthestakeholders’theory. Figure 2 is an illustration for the themes
emerged and the conceptual framework for this study.

Figure 2. Themes and conceptual framework.
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Emergent Theme 1: Leader’s Adaptability to Change
The first theme emerged from this study included the adaptability to the changes
that leaders are practicing in implementing the expansion strategy in MENA. The
changes, according to participants, are important because of the prevailing instability in
the region including the economical turbulences, currency devaluations, changes in
regulations for registrations, and enforcements of intellectual property rights (IPR) in
MENA. These multiple external factors affected the internal adaptability of the
organizations that included the requirements from leaders to develop understandings to
complywiththemarkets’demandsandchanges.
According to participants, leader’s effective application of the transformations
included effective communications of the changes that will reflect an effective
competitive advantage. The responses included developments of organizational values for
research and developments, business-to-business collaborations, training for human
resources, and strengthening the internal registration departments. Participants mentioned
that changes introductions because of the expansion strategy must align with the internal
production capacity and customers increasing demands. The effective application of the
balancing andalignmentincludedleader’sabilitytomotivateandpromoteforthe
expansion benefits. Figure 3 is for the Mindjet file for the codes I collected and the
emerged Theme 1.
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Figure 3. Mindjet illustration of the emerged Theme 1.
The emerged theme of leaders’adaptabilitytochangesisinalignmentwiththe
transformational leadership theory. The transfer for implementation is the short-term
planning, implementations, and control, which are the management's responsibility that
manifests the understanding of the enterprise level strategy (Elving et al., 2012). The
complexity of the information and the level of the uncertainty involved the efficient
strategy streamline performances with appropriate communication of the enterprise level
strategy for implementation (Montalban & Sakinç, 2013). Leaders with transformational
style are adaptable to changes through transforming organizational capacities that will
respond to the markets changes for competitive advantages (Dixit & Yadav, 2015).
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Transformational leadership is the leadership style that leaders apply to introduce
changes through motivations (Northouse, 2013).Managers’andsubordinates’
personalities, awareness, and culture alignment with organizational values is the leaders’
responsibility that introduces the appropriate change for strategy implementation (Donate
& Sánchez de Pablo, 2015). Knowledge management practices that leaders apply in the
organization motivate the acceptance to adapt changes for strategy implementation
(Ahmad et al., 2014). Abraham, Morin, Renaud, Saulquin, and Soparnot (2013) found a
significantrelationshipbetweenknowledgeexperts’expectationsfromapplyingchanges
and effective motivations that leaders applied.
Emergent Theme 2: Financial Capacity and Stability
The second theme emerged in this study was financial capacity and stability for
the expanding companies in MENA. Participants in this study mentioned the financial
ability of the organization and the financial management as a major factor for the
successful implementation of the expansion strategy. The financial records and
statements for the expanding companies included cash flow generations from the new
markets in MENA that involved profitable achievements. In addition, the investment
plans included requests for capital increases to align with the expansion strategy. The
investments plans included funds allocations for marketing and sales plans in the areas
that the companies are expanding in for the MENA, which is a requirement for effective
business competitiveness. Participants explained the financial allocations for the
strategies implementation as a major factor for the effective implementation of the
expansion and the financial statements confirmed the mentioned points of the
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participants. Figure 4 is for the Mindjet file for the codes I collected and the emerged
Theme 2.

Figure 4. Mindjet illustration of the emerged Theme 2.
The emerged theme of financial capacity and stability is in alignment with the
stakeholders’theoryoftheconceptual framework of this study. The primary stakeholders
in the expansion strategies are the investment sectors and the shareholders, for which
return on investment and increasing revenues are the key values for increasing the
financing of the expansion strategies of the pharmaceutical organizations (Tripathy &
Prajapati, 2014). Participants in this study indicated for the important implementation of
thefinancialplansinalignmentwiththeleaders’understandingsoftheMENA
challenges. Major challenges mentioned by participants included the MENA local
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authority’s protection for the local manufacturers, which implied changes in the
investment plans from sales expansions to collaborations expansion with targeted
countries’ local manufacturers. Such choices for expansion included risks of high
competition with multinationals that leaders must formulate a strategy to mitigate the
competition’s effect.
Pharmaceutical companies are examples of leadership resilience in the
challenging business and regulations environment because of new discoveries, financial
crises, generic introductions, intellectual property rights, good manufacturing practices
(GMP) development, and increased cost of innovation and development (Fisher,
Cottingham, & Kalbaugh,2015).Leader’s style, stakeholdersincludingshareholders’
orientation, knowledge, encouragement, and motivation were fundamentals for
pharmaceutical companies to maintain competitiveness and existences, which contributed
to innovative business models (Aslam, 2015). Such business models were introductory to
mergers, acquisitions, licensing, technology transfer, franchise, innovation outsourcing,
and products development (Michelino, Lamberti, Cammarano, & Caputo, 2015;
Nishimura & Okada, 2014; Srivastava & Prakash, 2014; Wang & Li-Ying, 2014).
Emergent Theme 3: Stakeholders’ Business Awareness
The thirdthemeemergedinthisstudywasthestakeholders’businessawareness
for the expanding companies. Pharmaceuticals manufacturing companies involve
scientific approaches to develop the business models of the expansion strategy
(Nagurney, Li, & Nagurney, 2013). In addition, the pharmaceuticals industry is a
regulated industry by the local and targeted countries authorities (FDA, 2001).
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Participants in this study stressed for the successful implementation of the expansion
strategythroughtheawarenessthatthestakeholdersgainfromtheorganizations’
activities and targets. The participants mentioned the stakeholders of the organizations
mainly as the shareholders, employees, regulatory, customers, and agents including the
remote communities in MENA.
The awareness of the shareholders included different levels for the expansion
strategy activities of (a) guidance to the management, (b) financial support, (c) approvals
for investments, and (d) accountability. Theemployee’sawarenessincludedthe
understanding of the expansion strategy from the gained experiences and the regulations
requirements,whichmaximizedtheemployees’involvementsforthedecision making
processes and successful implementation of the expansion strategy. MENA countries’
regulations, according to the participants, included lack of uniformed requirements for
registration. Therefore,theproduct’sdossierregistrationprocessesis changing from one
country to another, which included multiple costs and investments values. Participants
stressed that regulation authorities in MENA are not aware of the cost involved in the
multiple requirements and the different requirements from one country to another. The
participants found expansion in European Union (EU) countries more clear in
requirements than MENA. The intellectual property rights regulations enforcements in
MENA included restrictions for the generic producers in the region. Therefore, licensing,
technology transfer, know how sales, mergers and acquisitions, and collaborations were
strategies for expansion within the prevailing regulations in MENA according to
participants.
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Agents and customers are another stakeholders mentioned by the participants in
this study. The awareness for the expansion strategy by the agents and customers
included the acceptance, support, and facilitation for registration. The agents and
customers’ awareness of the expansion strategy included increases in sales and profits.
The increase in sales and profits is critical for the financial performances of the
organizations’cashflow,accordingtothefinancialstatementsoftheparticipants’
documents. Figure 5 is for the Mindjet file for the codes I collected and emerged Theme
3.

Figure 5. Mindjet illustration of the emerged Theme 3.
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The emerged theme of stakeholders’businessawarenessis in alignment with the
stakeholders’theoryoftheconceptualframeworkofthisstudy.Customers, shareholders,
employees, regulatory authorities, and society members are the affected parties of the
organizations’performances in addition to remote MENA communities of unanticipated
stakeholders, which are potential for the organization if communicated effectively for
expansions activities interests (Mitchell, Van Buren, Greenwood, & Freeman, 2015).
Technological advancement and accessibility are one of the millennium globalization
tools for searching and defining interests that potential stakeholders apply to gain
knowledgeaboutorganizations’performances(Tsai&Bagozzi,2014).Mitchell et al.
(2015) found stakeholders in the expansion strategy as critical communication factor for
the implementation that includes the expectations of the affected parties due to the
expansion activities. Therefore, stakeholders’awarenessfor the expansion strategy is
primitive for effective strategy implementation.
Stakeholders including the shareholders must benefit from the pharmaceutical
organization’s business expansion performance that enhances the leadership direction to
extendthemanagers’understandingsofthestakeholders’impacts(Kazadi et al., 2015).
The primary stakeholders in the expansion strategies are the investment sectors and the
shareholders, for which return on investment and increasing revenues are the key values
for increasing financings of the expansion strategies of the pharmaceutical organizations
(Tripathy & Prajapati, 2014). Pharmaceuticals manufacturing leaders leveraged the
competitive business advantages by maximizing the conversion value, lowering the costs,
first to serve the markets, and increasing the customer care efficiencies (Bartlett &
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Ghoshal, 2013). These processes improved information flows and application to create
the focus on the stakeholders’valuesleveraging.Suchvaluessecuredthesustainabilityof
the organization and provided the strategic competitive advantage that human resources
were a fundamental factor for advancement (Bartlett & Ghoshal, 2013).
The practical implementation of the sustainable strategy includes defining the
primary success factors for the analysis of the prevailing environmental factors
(Lindgren, 2012). In addition, Lindgren included the capabilities of the organization that
satisfiedthecustomers’long-term loyalty as a sustainable strategy for implementation, in
which the value chain of the organization reflected sustainability. Focus approach is a
successful way of identifying the primary success factors for pharmaceutical companies,
in which the strategy formulators balance the internal resources and external demands to
sustainthevalueobjectivesoftheenterprise’slong-term existences (Tatham & Spens,
2011; Teirlinck & Spithoven, 2013). Therefore, involving stakeholders in the expansion
strategyiscriticalfororganization’ssustainability.
Stakeholders are the directors of the organization activities and performances.
Freeman's(2010)definitionofstakeholdersdependedonorganizations’interactions
within the business environments, which include parties from internal and external
surroundings of the organization. Freeman extended the affected parties to include
governments, competitors, suppliers, employees and regulatory parties. The
organizations’activitiesinvolvechanges, benefits, and developments, in which social
interactions consequences affected the organization's strategic performance (Miles,
2012).
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The leaders of the organization deliver the long-termachievements’requirements
that fulfill the vision, mission, and values to the lower levels of the organization for
implementation. The transfer for implementation is the short-term planning,
implementations, and control, which are the management's responsibility that manifests
the understanding of the enterprise level strategy (Elving et al., 2012). The complexity of
information and the level of the uncertainty determine the efficient strategy streamline
performances, in which complex information and high uncertainty require effective
enterprise level strategy implementation (Montalban & Sakinç, 2013). The decrease in
complexity and uncertainty will downstream the strategy to corporate, business, and
functional level strategies that deal with more confirmed information and certain
processes and procedures (Andries et al., 2013). Kottke et al. (2013) found employees
withnoconfidenceinleadershipwouldnotacceptleadership’sideas,whichresultedin
lowscoreemployees’performances,employeestendedtosabotageleadershipstrategy,
and conflict of interest was a causeforemployees’confidenceslackinleadership.
Therefore, acceptance of change is a generation of leadership style and followers
perceptions that include mutual understanding and benefits.
Stakeholders’decisionsmay affect the resources allocation that organizational
leaders require for effective strategy implementation. Scheibehenne, Rieskamp, and
Wagenmakers (2013) provided theoretical framework using Bayesian inference technique
that uses beliefs and behaviors of individuals to determine the actions that individuals
make. Scheibehenne et al. (2013) indicated for the application of the model for the
expansion strategy, which could apply to the stakeholders as the primary influencers for
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the organization resources facilitation to understand the forces driving the decision
makingprocesses. Such forces might not include monetary benefits only but extend to
social, environmental, and pride values that the supply chain management, investment,
and purchasing behaviors of stakeholders control the organization activities and
expansion decisions for sustainable performances (Wolf, 2014). Therefore, knowing the
stakeholdersinfluencingneedsiscriticalfororganizations’leaderstoimplementthe
expansion strategy effectively.
Expansion strategy implementers are the managers in the organization. These
managers convert the strategy initiative into monetary values that the stakeholders
evaluate as returns on investment (ROI), which is the primary key performance indicator
(KPI) for the leaders and managers in the organization (Vallejo & Wehn, 2016). The
expansion strategy implementation includes stakeholders’ values fulfillment for ethical
performances of the ROI (Hahn & Lülfs, 2013). Analytical application of the expansion
strategy effectiveness for stakeholders’values is critical for the expansion strategy, which
indicates for the benefiting parties from investments and controls negatively affected
parties within the organizations’ activities (Öberseder, Schlegelmilch, & Murphy, 2013).
Therefore, managers in expansion strategy implementation must acquire the stakeholders’
ethical values for effective strategy implementation.
Emergent Theme 4: Managers’ Engagement and Knowledge.
The fourththemeemergedinthisstudywasmanagers’engagementand
knowledge. Participantsinthisstudyfocusedonthemanagers’contributionstothe
expansionstrategyaccordingtothemanagers’knowledgeandlevelsofengagementsin
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theorganizations’hierarchies.Theparticipantsmentionedexperienced managers in the
expansion strategy as a major implementers and contributors to the strategy designs,
which the organization mission and vision statements included. Participants posited that
engagement of managers in the expansion strategy designs facilitated the appropriate
implementation and raised the awareness for the requirements particularly in MENA
turbulentmarkets.Thecompliancerequirementsfortheproducts’dossiers,themarketing
effectiveness, the deliveries of products, and production requirements were
responsibilities forthedepartments’managers’forimplementingtheexpansionstrategy,
according to participants in this study.
Participants’answersforthemanagers’qualificationsandabilitiesincludedthe
importance of acceptance of ideas from others, low resistance to change, organizational
culture, team working, collaboration with external parties, and flexibility. Some
participants applied the balanced score cards (BSCs) system for the evaluation of the
performances and task distribution that involved managers’engagements and
implementations.TheKPIsareothersystemsforevaluationofthemanagers’
contributions for the expansion strategy according to some participants. Participants
mentioned the importance of training and continuous education as appropriate tools for
managers’improvementstoincreasetheexpansionstrategyeffectiveness. Figure 6 is for
the Mindjet file for the codes I collected and the emerged Theme 4.
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Figure 6. Mindjet illustration of the emerged Theme 4.
The emerged theme of managers’engagement and knowledge is in alignment
withtransformationalleadershiptheoryandstakeholders’ theory of the conceptual
framework for this study. Expansion strategy in organizations is a development process
that includes innovation and creativity. Transformational leader practices initiations and
supports innovation and creativity, which is a critical change for competitive advantage
(Schriber & Löwstedt, 2015).
Burgess (2013) found critical relationship between communication style
management and leader’sdecisionmaker,whichformedadvancementsduetosharing
and engaging of strategy implementers in decision makingprocesses for the organization.
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Transformational leaders apply engagement practices that the communication, trust,
motivation, and awareness are functional processes for developing mutual understandings
forthesustainableorganizationincompetitivebusinessmarkets(Men,2014).Leaders’
understandings of followers are significant in decision makingpractices that leaders
needed to introduce changes and leverage performance (Kottke et al., 2013). Leaders
mustacquirethebusinessaswellasbehavioralinfluencestodevelopfollowers’
knowledge that target the learning processes in the organizations to the advancement and
competitiveness (Epitropaki, Sy, Martin, Tram-Quon, & Topakas, 2013). Competent
leaders can forward influences in the organizational structure that the business
environment is changing because of external factors affecting organization performances
(Parnell, Lester, Long, & Köseoglu, 2012). Leaders in such conditions are the finders of
therequiredeffectiveperformancesthatmaintainorganizations’existence,particularly,
during a crisis or changing regulations (Petrou, Demerouti, & Häfner, 2015).
The leaders focus must include appointing capable managers for the expansion
strategy in the right strategy task, in which managers align the effect of the
implementation of the strategy and organization objectives actively (Akhavan &
Pezeshkan, 2014). Managers as strategy implementers need to understand the actions and
initiatives that link with organization values, cultures, and objectives for better
performance in the strategy execution (Green, Albanese, Cafri, & Aarons, 2014).
Friedrich von den Eichen, Freiling, and Matzler (2015) discussed the reasons for failing
businessmodels,whichincludedmanagementrejectionduetolackofmanagers’
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awareness, defining proper research about the business model, logic application, and
cultural differences.
Leaders’knowledgeaboutthemanagers’stylesandthinkingpracticesisa
requirement for the application for appointing managers for strategy implementation.
Successful strategy implementation is a process that requires the utilization of business,
technical, and managerial competencies. Liang, Howard, Koh, and Leggat, (2013) studied
thecriticalmanagers’competenciesthatmanagersmustacquiretodeliverorganization’s
objectives. Liang et al. (2013) accounted for interpersonal communication qualities,
operations’resourcesmanagement, leading change management, and decision making
management as primary competencies for managers to achieve the strategy objectives in
organizations.TrongTuan(2012)foundasignificantrelationshipbetweenmanagers’
transformational behavior and business targets effectiveness, which improved business
outcomes and advanced organization image. Managers in advancing business
effectiveness in organizations must combine technical and business qualification that
leveragethestakeholder’sinterestandattainbusiness profitability (Miles, 2012). In
addition,theorganization’sbusinessperformanceisastakeholder’sinterest,which
managers maintain for effective business expansion and sustainability.
Practitioners’andscholars’studiesinpharmaceuticalindustries included
innovationcompetenciesthatmanagers’applytoleverageedgeforcompetitive
advantages (Epitropaki et al., 2013; Hu, McNamara, & McLoughlin, 2014; Kim, 2014;
Montalban & Sakinç, 2013; Pollock, 2014). The innovation practices in pharmaceutical
industries included introductions of business models for expansion strategy to enhance
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business effectiveness (Erden, Klang, Sydler, & von Krogh, 2014). Montalban and
Sakinç (2013) examined the effects of financialization and competition on productive
models in pharmaceutical companies. Montalban and Sakinç found pharmaceutical
companies’adaptationsofblockbustermodelmaximizedshareholdervalue,which
included financialization, technical change, product market regulations, and market
competition. Montalban and Sakinç concluded that institutional investors are accelerators
fortransformationalbusinessmodelsthatmustalignwithmanagers’controlsand
practices during expansion strategy implementation as an effective business model for
competitive advantage. Therefore, selecting business expansion model for pharmaceutical
industriesmustalignwithmanagers’organizationalcompetencies,externalmarkets’
competitions,andstakeholders’demands.
Business expansion models are part of the corporation strategy for growth and
profitgenerationthatleadersformulatebydependingonthecorporation’scomponents
andmanagers’motives,competences,understandings,andqualificationstoachievethe
strategy targets (Martin, 2014). Enterprise managerial levels are important formulators of
the appropriate expansion strategy and method of implementation, which decision
makingprocess involved (Chen, Liu, Ni, & Wu, 2015). Chen et al. (2015) examined the
relationship between strategic intent and external business factors affecting expansion
strategy. Chen et al. found a significant relationship between the variables and posited
that expansion strategy and decision makingprocesses must align with intentional and
organizational capacities to achieve successful expansion strategy implementation.
Therefore, expansion strategy includes multiple factors of the decision makingprocess
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that leaders and managers must acquire to select the appropriate expansion strategy
within or outside the business constructs of the organization.
Applications to Professional Practice
Theapplicationofleader’sadaptabilitytochange,financialcapacityandstability,
stakeholders’businessawareness,andmanagers’engagementand knowledge are
relevant to the professional business practices. Pharmaceutical leader’s expansion
strategies include introductions of changes in the acquired systems to align capacities
(Daems et al., 2014). The capacities alignment of the changes, financings, businesses,
stakeholders, and managers are critical practices for implementing successful expansion
strategy to achieve commercialization targets.
The findings from this study are of value to business because leaders of strategy
designers in pharmaceutical organizations need to account for the sustainability,
potentials, and capacities to provide valid and reliable expansion strategies. Business
expansion models are part of the corporation strategy for growth and profit generation
that leaders formulatebydependingonthecorporation’scomponentsandmanagers’
motives, competences, understandings, and qualifications to achieve the strategy targets
(Martin, 2014). The findings from this study are developments and combinations of the
conceptual framework applied from transformationalleadershiptheoryandstakeholders’
theory that included explorations of effective application of the expansion strategy for
competitive advantages of successful applications. Therefore, pharmaceuticals business
advancementinexpansionstrategymaycombinethetransformationalleader’smindset
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and stakeholders benefits from the organization activities to achieve the competitive
advantage.
The application of purposeful sample in this study included CEOs and managers
from the Jordanian generic pharmaceutical companies. All participants, worked for more
than 10 years in the expansion strategy for the organization. The findings from the
semistructured interviews, documents reviews, and member checking confirmation
included an appropriate foundation for business consideration of expansion strategy that
involveadaptabilitytochange,financialcapacityandstability,stakeholders’business
awareness,andmanagers’engagementandknowledge.
Leader adaptability to change is institutional in organizational formation and
business advancement practices (Filiou & Golesorkhi, 2014). Relationship between the
internal organizational changes requirement for development and the gaining from
expansion strategy that the partnering, outsourcing, regulatory attainment or knowledge
sharing implied during the process implementation is critical for adaptability to change
practices (Bellamy, Ghosh, & Hora, 2014). Therefore, awareness for adaptability to
change is critical for leaders and managers during the implementation of the expansion
strategy.
Financial capacity and stability is a critical application for the expansion strategy
practices. Shareholders, investors, and stockholders are business value accouters for the
organizations’activities and performances. Expansion strategy includes ROI and sales
revenues from markets. The effective application of the capital or cash flow, financing
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strategies, and expense control are requirements for business practices for the expansion
strategy.
Theprofessionalparticipantsinthisstudyindicatedforthestakeholders’business
awareness importance. The awareness of the organization activities from stakeholders
includes the utilization of corporate transparency practices to achieve internal capacities
development requirements and external capacities market access that involved expansion
strategies (Tripathy & Prajapati, 2014). Pharmaceutical industries constitute of divers,
integrate objective, and interactive systems in complex changing business and scientific
climate (Nagurney, Li, & Nagurney, 2013).
The scientific nature of the pharmaceutical industries and knowledge base
formation including the high impact on the lives of the intended consumers guided the
international healthcare organizationstoregulatethepharmaceuticalcompanies’
activities through enforcing GMP (Frau, Font Pous, Luppino, & Conforti, 2010). These
regulationsareforcontrollingandinspectingthesystems’operationsasanintegralpart
of the market authorization requirements (Yadav, 2013). The registration of dossiers and
the time the research and development included are factors for awareness of the longterm investments. Therefore, awareness is functional business processes for developing
mutual understandings for the sustainable organization in competitive business markets
(Men, 2014).
Participants in this study worked for more than 10 years in expansion strategies.
Form the conducted interviews thethemeofmanagers’engagementandknowledge
emerged as a resultfromthequestionsaboutcontributor’sabilitytoimplementthe
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expansionstrategy.Thepracticalapplicationofmanagers’engagementsinthe
organization’sstrategyformulationandimplementationdependedontheknowledgethat
managers acquired from experiences, education, skills, and exposures. Leaders’
encouragementsandmotivationsincludeemployees’engagementsinsharingchange
management benefits and valuing performances (Güntert, 2015). Therefore, business
applicationofthemanagers’engagementand knowledge is important for leaders to
developthestructuralstrategyformulator’sknowledgethatleadersrequiredfromthe
managers for implementing the expansion strategy.
Implications for Social Change
Pharmaceutical industries are scientific knowledge base industries that include
scientificdiscoveries,marketpreferences,regions’demands,andepidemicsfighting
within the business construct to achieve social and economic targets (Belderbos, Gilsing,
& Suzuki, 2015). Generic pharmaceutical industries in the middle-income regions of
MENAprovidedsolutionsforthepharmaceutical’savailability,inwhicheffective
strategiesimplementationforthepharmaceutical’sbusinessexpansioncontributedto
profits generation in the targeted MENA regions (Cameron et al., 2012). In 2013, generic
pharmaceutical business leaders failed to develop a business expansion strategy to satisfy
demands of $26.2 billion supplies of essential medicines for developing countries in the
MENA communities (UN Millennium Development Goals, 2014). These communities
are potential stakeholders who could gain benefits by increasing generic medical supplies
therebymeetingbothphysiciansandpatients’needsforincreasingavailabilityand
decreasing costs of generic pharmaceuticals to fight diseases.
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Fighting diseases is a major implication for social change in this study. The
generic pharmaceutical manufacturers’leaders in the MENA may apply the findings in
this study of leader’sadaptabilitytochange,financialcapacityandstability,
stakeholders’businessawareness,andmanagers’engagementandknowledge.The
application of the findings from this study may respond to the UN
Millennium Development Goals (2014) for fighting disease with generic essential
medication that can save the lives in low-income regions in MENA and respond to the
implementation of the expansion strategy. The expectations from the findings application
are to provide the generic pharmaceutical leaders and managers with increased
capabilities for catalyzing beneficial social changes by capacity expansion strategies. The
subsequent expansion could provide adequate, affordable, and accessible medications for
effecting social change in the remote MENA communities.
Organizations with expansion strategies for social change are benefiting from the
inclusion of social changes in vision and mission statements that guided the leaders,
managers, and employees performances. Shareholders and leaders are interested in
promotingthesocialchangesthatthecompanies’expansionstrategiesincludethrough
integrated sustainability initiatives (Alakent & Ozer, 2014). Franks et al. (2014)
recognized expansion strategies including corporate-culturalsocialchanges’intentions as
an advancement of corporate sustainability. The findings from this study are applicable
for the alignments of the social change statements in the vision and mission statements of
the organizations for the increasing interactions between communities and organizations.
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Recommendations for Action
The purpose of this qualitative descriptive multiple case study was to explore
effective application of expansion strategy among Jordanian pharmaceutical managers to
satisfy the demand in the MENA markets. Generic pharmaceutical manufacturers in
MENA region could apply the findings from this study to benefit from the effective
application of the expansion strategy implementation. Organizations in MENA with
expansion strategy focus may benefit from the findings of this study because
implementations of the expansion strategy involve similar requirements for the business
models. The steps for useful action of the findings from this study may include the
following recommendations.
Recommendation 1 is for development of the business awareness between the
stakeholdersoftheorganizations.Leaders’abilitytochangeisthedevelopmentofthe
awarenessofthebusinesschangesandexternalfactorsthataffecttheorganization’s
activities. MENA region according to participants is changing with the economic
instability and currencies devaluations. Therefore, leaders adapting changes with
introduction of collaborations, business-to-business, or licensing is an option for
expansions, which mitigate risks and develop relationships (Bellamy et al., 2014).
Managers in pharmaceutical industries are developing knowledge, skills from
scientific backgrounds, and experiences of the fields of the industry because of the
regulatory codes for the management qualification for“safe,pure,andeffective”
pharmaceuticalproducts’manufacturing (FDA, 2001). Recommendation 2 is for
pharmaceutical managers who must acquire business knowledge according to participants
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in this study. Participants in this study mentioned the benefits of business training,
business courses, and business educations including the technical scientific knowledge
for implementing successful expansion strategies in the organizations.
Recommendation 3 is for the educational institutions, associations, and trainers
for pharmaceutical and scientific courses who may benefit from the findings of this study.
The inclusion of practical courses for business education for pharmacy, engineering,
chemistry, or biology courses will increase the business awareness of the scientific
activities in universities and research departments in the pharmacy fields. Participants in
this study were from scientific background and stressed for the importance of business
awareness among stakeholders of the pharmaceutical industries.
Recommendation 4 is for leaders to involve shareholders in the requirements for
log-term investments with clear feasibility studies and business plans for critical funds
approvals, according to the participants in this study. For the expansion strategy
implementation, resources are critical factor for the executions (Casado & Peláez, 2014).
Theresourcesacquirementsareshareholders’responsibilityforapprovals (Teirlinck &
Spithoven, 2013). Therefore, managers must provide and build adequate studies and trust
to gain approvals for the investments from the shareholders.
The findings from this study may interest pharmaceutical and industrial leaders
includinghealthcareorganizationsandhealthcareeducationalsystems’leaders.The
MENA pharmaceutical manufacturers associations may gain benefits from the findings in
this study. In addition, managers in healthcare services and industries may find benefits
form the finding in this study. The four themes emerged from this study and the four
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recommendations are offering applicable practices for organizations with similar
structures of the generic pharmaceutical industries.
My intention is to disseminate the finding form this study in local conferences for
the pharmaceutical manufacturers. The Jordanian association of pharmaceutical
manufacturers (JAPM) is a professional’s local association, which I intend to submit the
findings of this study for publishing. I plan to publish an article about the finding of this
study in peer-reviewed journals like Journal of Health Economics, Industrial Marketing
Management, or International Business Research. I will prepare a presentation for the
findings from this study for Jordanian pharmaceutical manufactures who participated in
this study for organizational training seminars.
Recommendations for Further Research
This qualitative multiple case study included sample form Jordanian
pharmaceutical companies who practiced the expansion strategy in MENA region for
more than 10 years. The participants in this study shared some ideas according to
question 12 , which included recommendations for further research. The
recommendations for further research may include the exploration of the business efforts
for compliances in MENA regulations for pharmaceuticals registration and marketing and
the cost of the replications encountered because of fragmented requirements.
Quantitative researchers may conduct further research on the relationships
between the themes emerged from this study. I recommend the further quantitative
researchabouttherelationshipbetweenthemanagers’competenceinexpansionstrategy
and the financial performances for the generic pharmaceutical companies in MENA. In
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addition, further quantitative researchers may study the relationship between
shareholders’awarenessoftheexpansionstrategyeffectivenessandmanagers’
engagements and knowledge about the expansion strategy.
The limitations of the qualitative case study include the small sample size
involved in the study (Ercikan & Roth, 2014). Therefore, further research may include
larger sample size. In addition, the geographical boundaries in this case study design
included limitations for Jordanian pharmaceutical companies, therefore, I recommend
further research that include firms from MENA pharmaceutical companies. One
limitation of this study include the exploration of pharmaceutical industries in Jordan, I
recommend further research to include other similar industries with expansion strategy
practices for the MENA region.
Reflections
In reflection of the DBA study program, I learned many academicals values and
requirements for conducting research studies, particularly, during this research study. The
new information I learned by practicing research methods included changes in my
perceptions for the values of the research and researchers. The complexity of the
interpretations that researches must view and keep the focus on the research topic was a
new learning practice for me in this research study. Patience is a critical factor for the
researchers that I learned from this study. Visiting the offices of the participants, calling
for interview appointments, and the perceived intention of different participants was
additional learning for me about the confidence of the successful implementers of the
expansion strategy, who accepted and appreciated participation.
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In my role as a researcher, I was able to keep my focus on the research topic and
avoid any personal bias or preconceived information. I asked the interview questions and
in some cases, I asked further questions to confirm my understanding of the answers or
clarify the interpretation. I applied the member checking process to confirm my
interpretation of the answers before starting the data analysis process.
My respect to research and researchers increased after conducting this study. I
was able to learn from the literature review, which I conducted for this research, but I
confirmed the learned topics with practicing. I now have a new approach to confirm and
judge facts not opinions. I practiced effective listening to participants with great respect,
by avoiding interruption and keeping the focus on the answers. My thinking of the
emerged themes from this study changed the way that I used to think about the practices
of managers in pharmaceutical industries. The managers participated in this study were
from different backgrounds, educational fields, and accountability levels in the
organizations’hierarchy.Theemergedthemesfromtheanswersofthemanagers’
participants included changesinmyviewstothemanagers’qualificationsand
competences for the pharmaceutical field. These requirements ignored or granted
managers knowledge about basics of business.
Conclusion
Successful expansion strategy implementation is a characterization for the
qualified implementers of the strategy. The qualification of the implementers of the
expansion strategy includes the contributions of multiple advancements and
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developments of the stakeholders of the organization. The knowledge awareness and
distributions is critical for the successful implementations of the expansion strategy.
The purpose of this qualitative descriptive multiple case study was to explore
effective application of expansion strategy among Jordanian pharmaceutical managers to
satisfy the demand in the MENA markets. I collected data from interviews with CEOs
and managers from generic pharmaceutical companies in Jordan who practiced and
succeeded in applying expansion strategies in the MENA region and reviewed documents
of financial statements for the data triangulation. I selected participants purposely from
the Jordanian pharmaceutical managers with the professional application of expansion
strategies in MENA markets. I applied member-checking process for the validity of the
research. I reached the data saturation after I received no new information and the data
were repetitive. I defined the data saturation point after conducting the seventh
participant’sinterview.
Thefourthemesemergedfromthedataanalysisforthisstudywere(a)leader’s
adaptability to change, (b) financialcapacityandstability,(c)stakeholders’business
awareness,and(d)managers’engagementandknowledge.Iconfirmedthethemes
emerged with the literature I reviewed in this study and the existing body of knowledge. I
included the linking between the emerged themes and the conceptual framework of this
studythatincludedthetransformationalleadershiptheoryandstakeholders’theory.
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Appendix A: NationalInstituteofHealthCertificate“ProtectingHumanResearch
Participant”
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Appendix B: List of Interview Questions
1. What strategies do you use for expanding generic pharmaceutical capacity for the
MENA customers?
2. What challenges did or do you face in implementing the business expansion
strategies for this organization?
3. What are core business processes that improve expansion strategy in this
organization?
4. What are the principal barriers you faced or are facing in implementing the
expansion strategy?
5. How do you communicate and address the barriers with subordinates working in
expansion strategy?
6. How did or do you address the principal barriers solutions or overcome in your
expansion strategy?
7. How do you evaluate expansion strategies implementations?
8. Whataremanagers’contributionstoexpansionstrategies?
9. Howaremanagers’capabilitiessupportingexpansionstrategiesinMENAregion?
10. What are supports you needed or need from shareholders to address the expansion
strategy?
11. How do you align the expansion strategy with the production capacity design?
12. What are other information you might share about your development and
implementation of expansion strategies for generic pharmaceuticals in MENA
region?
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Appendix C: Mindjet Map of the Relationships between the Themes

